<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html lang="en" xml:lang="en" xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">


<meta name="wpd_version" content="0.2">
<meta name="wpd_baseurl" content="http://www.jimmunol.org/content/176/11/6973.full">
<meta name="wpd_url" content="http://www.jimmunol.org/content/176/11/6973.full">
<meta name="wpd_date" content="2013-04-14T10:58Z">

      
      <title>Maintenance of HIV-Specific CD4+ T Cell Help Distinguishes HIV-2 from HIV-1 Infection </title>
      <meta name="googlebot" content="NOODP">
      <meta name="HW.ad-path" content="/cgi/content/full/176/11/6973">
      <meta content="/jimmunol/176/11/6973.atom" name="HW.identifier">
      <meta name="DC.Format" content="text/html">
      <meta name="DC.Language" content="en">
      <meta content="Maintenance of HIV-Specific CD4+ T Cell Help Distinguishes HIV-2 from HIV-1 Infection" name="DC.Title">
      <meta content="" name="DC.Identifier">
      <meta content="2006-06-01" name="DC.Date">
      <meta content="American Association of Immunologists" name="DC.Publisher">
      <meta content="Melody G. Duvall" name="DC.Contributor">
      <meta content="Assan Jaye" name="DC.Contributor">
      <meta content="Tao Dong" name="DC.Contributor">
      <meta content="Jason M. Brenchley" name="DC.Contributor">
      <meta content="Abraham S. Alabi" name="DC.Contributor">
      <meta content="David J. Jeffries" name="DC.Contributor">
      <meta content="Marianne van der Sande" name="DC.Contributor">
      <meta content="Toyin O. Togun" name="DC.Contributor">
      <meta content="Samuel J. McConkey" name="DC.Contributor">
      <meta content="Daniel C. Douek" name="DC.Contributor">
      <meta content="Andrew J. McMichael" name="DC.Contributor">
      <meta content="Hilton C. Whittle" name="DC.Contributor">
      <meta content="Richard A. Koup" name="DC.Contributor">
      <meta content="Sarah L. Rowland-Jones" name="DC.Contributor">
      <meta content="The Journal of Immunology" name="citation_journal_title">
      <meta content="J Immunol" name="citation_journal_abbrev">
      <meta content="0022-1767" name="citation_issn">
      <meta content="1550-6606" name="citation_issn">
      <meta name="citation_author" content="Melody G. Duvall">
      <meta name="citation_author" content="Assan Jaye">
      <meta name="citation_author" content="Tao Dong">
      <meta name="citation_author" content="Jason M. Brenchley">
      <meta name="citation_author" content="Abraham S. Alabi">
      <meta name="citation_author" content="David J. Jeffries">
      <meta name="citation_author" content="Marianne van der Sande">
      <meta name="citation_author" content="Toyin O. Togun">
      <meta name="citation_author" content="Samuel J. McConkey">
      <meta name="citation_author" content="Daniel C. Douek">
      <meta name="citation_author" content="Andrew J. McMichael">
      <meta name="citation_author" content="Hilton C. Whittle">
      <meta name="citation_author" content="Richard A. Koup">
      <meta name="citation_author" content="Sarah L. Rowland-Jones">
      <meta content="Maintenance of HIV-Specific CD4+ T Cell Help Distinguishes HIV-2 from HIV-1 Infection" name="citation_title">
      <meta content="06/01/2006" name="citation_date">
      <meta content="176" name="citation_volume">
      <meta content="11" name="citation_issue">
      <meta content="6973" name="citation_firstpage">
      <meta content="6981" name="citation_lastpage">
      <meta content="176/11/6973" name="citation_id">
      <meta content="jimmunol;176/11/6973" name="citation_mjid">
      <meta content="http://www.jimmunol.org/content/176/11/6973.abstract" name="citation_abstract_html_url">
      <meta content="http://www.jimmunol.org/content/176/11/6973.full" name="citation_fulltext_html_url">
      <meta content="http://www.jimmunol.org/content/176/11/6973.full.pdf" name="citation_pdf_url">
      <meta content="http://www.jimmunol.org/content/176/11/6973" name="citation_public_url">
      <meta content="16709858" name="citation_pmid">
      <meta name="citation_section" content="HOST DEFENSE">
      <meta name="robots" content="noarchive,nofollow">
      <meta name="googlebot" content="noarchive">
      <link href="http://www.jimmunol.org/content/176/11/6962.short" rel="prev">
      <link href="http://www.jimmunol.org/content/176/11/6982.short" rel="next">
      
      
      
      
      
      
      
      <script type="text/javascript" id="session-d160074263e1">var callbackToken='4623D56557BCCAA';</script><script type="text/javascript" src="jquery-min.js"></script><script type="text/javascript" src="hw-shared.js"></script><script type="text/javascript" src="hw-design1.js"></script><script type="text/javascript" src="adsheader.js"></script><script type="text/javascript" src="hw-content.js"></script><script type="text/javascript" src="AccessCheckLib.js"></script><script type="text/javascript" src="executeAccessCheck.js"></script><script type="text/javascript" src="jquery.fancybox-1.3.4.js"></script><script type="text/javascript" src="jquery.easing-1.3.pack.js"></script><script type="text/javascript" src="jquery.mousewheel-3.0.4.pack.js"></script><script type="text/javascript" src="content.jquery.addVariantLink.js"></script><script type="text/javascript" src="hw-col-expand.js"></script><script type="text/javascript" src="content-box-oa.js"></script>
<link rel="stylesheet" type="text/css" href="6973.css" media="all">
</head>
<body>
      <div id="dic_bubble" class="selection_bubble fontSize13 noSelect" style="z-index: 9999; border: 1px solid rgb(74, 174, 222); visibility: hidden; top: 902px; left: 595px; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-size: 10pt; font-family: Helvetica;"><div class="selection_bubble_content"><div class="selection_bubble_word" id="selection_bubble_word">		<img src="closeIcon.png" id="selection_bubble_close" align="right"><span style="font-weight: bold; padding-right: 10px;">asymptomatic</span><span style="padding-right: 5px; font-size: 12px;"><img style="position: relative; top: 4px; display: inline; cursor: pointer;" src="Audioicon.png" id="playSound"></span><span class="selection_bubble_align_with_spearker">[<span style="padding-right: 2px;"> ey-simp-t<span class="dbus_pron_i">uh</span>-<span class="dbus_pron_b">mat</span>-ik, ey-simp-</span>]</span><span id="soundBox">&nbsp;</span></div><div id="dic_bubble_difinition">		<i class="selection_bubble_title">adjective</i>		<div id="dic_bubble_dif" class="dic_dif"><div class="item"><div class="itemCount">1.</div><div class="itemData"> showing no evidence of disease.</div></div></div></div> <div id="dic_bubble_synonyms"> <div class="selection_bubble_synonyms">synonyms</div> <div id="selection_bubble_defintion"><span><a href="http://www.jimmunol.org/browse/"></a></span></div></div><div id="selection_bubble_more_action">		<span>			<a href="http://app.dictionary.com/click/hbnm17?clkdest=http://dictionary.reference.com/browse/asymptomatic" target="_top">				<img src="more.png" alt="Dictionary More">			</a>		</span>		<a href="http://app.dictionary.com/click/rovvlr?clkdest=http://dictionary.reference.com/" target="_top">			<img style="position: relative; bottom: 5px;" src="pop-up_logo.png" alt="Dictionary.com" align="right">		</a> </div></div><div class="dic-arrow-below" style="left: 250px;"></div><div class="dic-bubble-arrow-below" style="border-bottom: 20px solid rgb(255, 255, 255); left: 250px;"></div></div><div class="hw-gen-page pagetype-content" id="pageid-content" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle">
         <div id="header">
            <img id="main-logo" title="Journal Name" src="journal_logo.gif" alt="Journal Logo">
            
            <p id="skip-link">
               <a href="#content-block">Skip to main page content</a>
               
            </p>
            
            <ul class="button-list header-buttons">
               <li class="first"><a href="http://www.jimmunol.org/" title="HOME"><span>HOME</span></a></li>
               <li><a href="http://www.jimmunol.org/site/misc/infoforauthor.xhtml#aboutjournal" title="ABOUT"><span>ABOUT</span></a></li>
               <li><a href="http://ji.msubmit.net/" title="SUBMIT"><span>SUBMIT</span></a></li>
               <li><a href="http://www.jimmunol.org/site/misc/authorinstructions.xhtml" title="AUTHOR INFO"><span>AUTHOR INFO</span></a></li>
               <li><a href="http://www.jimmunol.org/archive/" title="ARCHIVE"><span>ARCHIVE</span></a></li>
               <li><a href="http://www.jimmunol.org/subscriptions/" title="SUBSCRIBE"><span>SUBSCRIBE</span></a></li>
               <li><a href="http://www.aai.org/About/Publications/JI/copyright.html" title="PERMISSIONS"><span>PERMISSIONS</span></a></li>
               <li><a href="http://www.jimmunol.org/site/misc/addir.xhtml" title="ADVERTISE"><span>ADVERTISE</span></a></li>
               <li><a href="http://www.jimmunol.org/cgi/feedback" title="CONTACT"><span>CONTACT</span></a></li>
               <li class="last"><a href="http://www.jimmunol.org/help/" title="HELP"><span>HELP</span></a></li>
            </ul>
            
            
            <div class="header-qs">
               
               <form class="searchbox" action="http://www.jimmunol.org/search" method="get">
                  <div>
                     	<label for="header-qs-input" id="header-qs-search-label">Search The JI</label>
                     	<input style="color: rgb(160, 160, 160);" value="Search The JI" title="Search" name="fulltext" id="header-qs-input" type="text"><input name="submit" value="yes" type="hidden"><a href="#" id="hdr-qs-search-a"><label for="header-qs-search" id="header-qs-search-label">GO</label></a><input value="GO" alt="Link: Go" id="header-qs-search-go" src="go.gif" type="image">
                     
                  </div>
                  <div class="adv-search-link"><a href="http://www.jimmunol.org/search">Advanced »</a></div>
               </form>
               
               
            </div>
            
            <div class="header-ac-elements">
               
               <div class="inst-branding">
                  
               </div>
               
               <div id="authstring">
                  
                  
               </div> 
               
               
               <div id="hdr-login">
                  
                  <form action="http://www.jimmunol.org/login" method="post">
                     <div>
                        <label for="hdr-login-username" id="hdr-login-username-label">User Name</label>
                        <input style="color: rgb(160, 160, 160);" name="username" id="hdr-login-username" type="text">
                        <label for="hdr-login-password" id="hdr-login-password-label">Password</label>
                        <input style="color: rgb(160, 160, 160);" name="code" id="hdr-login-password" type="password">
                        <a href="#" id="hdr-login-signin-label-a"><label for="hdr-login-signin" id="hdr-login-signin-label">

                           Sign In
                           </label></a>
                        <input style="color: rgb(160, 160, 160);" value="http://www.jimmunol.org/content/176/11/6973.full" name="uri" type="hidden">
                        <input style="color: rgb(160, 160, 160);" alt="sign in" value="
                           Sign In
                           " id="hdr-login-signin" src="login.gif" type="image">
                        
                     </div>
                  </form>
                  
               </div>
               
            </div>
            
            <div class="banner-ads">
               
               <ul>
                  <li class="position-ad">
                     <script type="text/javascript" src="oasis-top.js"></script>
                     </li>
                  <noscript>

                     <A HREF="http://ahs2.adhostingsolutions.com/oasisc.php?s=1885&amp;w=468&amp;h=60&amp;t=_blank"><img SRC="http://ahs2.adhostingsolutions.com/oasisi.php?s=1885&amp;w=468&amp;h=60&amp;u=ahs2.adhostingsolutions.com&amp;t=_blank"
                             width="468"
                             height="60"
                             border="0" /></A>
                  </noscript>
               </ul>
               
            </div>
            
            <div class="bar">
               
               <div class="bar-inner"></div>
               
            </div>
            
         </div>
         <div style="height: auto;" id="content-block"><div class="" style="display: block; left: 985.5px;" id="content-option-box" title="Expand this column"><ul><li id="content-toggle"><a href="#"><span class="descr">Expand</span><span>+</span></a></li></ul></div><div id="print-slug" class="print-only"><span class="jnl-title">The Journal of Immunology</span><span class="jnl-url">www.jimmunol.org</span><div class="cb-section cb-slug">
                     <ol>
                        <li>
                           <div id="slugline">
                              
                              
                              	    
                              
                              <cite>
                                 	    <abbr title="The Journal of Immunology" class="slug-jnl-abbrev">

                                    The Journal of Immunology</abbr><span class="slug-pub-date" itemprop="datePublished">

                                    	    June 1, 2006 
                                    </span>
                                 	    <span class="slug-vol">

                                    vol. 176 
                                    </span><span class="slug-issue">

                                    no. 11 
                                    </span><span class="slug-pages">

                                    6973-6981
                                    </span>
                                 </cite>
                              
                              
                              
                           </div>
                        </li>
                     </ol>
                  </div></div>
            <div class="article fulltext-view" itemprop="articleBody"><span class="highwire-journal-article-marker-start"></span><div class="article fulltext-view">
                  <h1 id="article-title-1" itemprop="headline">Maintenance of HIV-Specific CD4<sup>+</sup> T Cell Help Distinguishes HIV-2 from HIV-1 Infection<a id="xref-fn-2-1" class="xref-fn" href="#fn-2"><sup>1</sup></a></h1>
                  <div class="contributors">
                     <ol class="contributor-list" id="contrib-group-1">
                        <li class="contributor" id="contrib-1" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search" href="http://www.jimmunol.org/search?author1=Melody+G.+Duvall&amp;sortspec=date&amp;submit=Submit">Melody G. Duvall</a></span><a id="xref-aff-2-1" class="xref-aff" href="#aff-2"><sup>*</sup></a><span class="xref-sep">,</span><a id="xref-aff-4-1" class="xref-aff" href="#aff-4"><sup>‡</sup></a>, 
                        </li>
                        <li class="contributor" id="contrib-2" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search" href="http://www.jimmunol.org/search?author1=Assan+Jaye&amp;sortspec=date&amp;submit=Submit">Assan Jaye</a></span><a id="xref-aff-3-1" class="xref-aff" href="#aff-3"><sup>†</sup></a>, 
                        </li>
                        <li class="contributor" id="contrib-3" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search" href="http://www.jimmunol.org/search?author1=Tao+Dong&amp;sortspec=date&amp;submit=Submit">Tao Dong</a></span><a id="xref-aff-2-2" class="xref-aff" href="#aff-2"><sup>*</sup></a>, 
                        </li>
                        <li class="contributor" id="contrib-4" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search" href="http://www.jimmunol.org/search?author1=Jason+M.+Brenchley&amp;sortspec=date&amp;submit=Submit">Jason M. Brenchley</a></span><a id="xref-aff-4-2" class="xref-aff" href="#aff-4"><sup>‡</sup></a>, 
                        </li>
                        <li class="contributor" id="contrib-5" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search" href="http://www.jimmunol.org/search?author1=Abraham+S.+Alabi&amp;sortspec=date&amp;submit=Submit">Abraham S. Alabi</a></span><a id="xref-aff-3-2" class="xref-aff" href="#aff-3"><sup>†</sup></a>, 
                        </li>
                        <li class="contributor" id="contrib-6" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search" href="http://www.jimmunol.org/search?author1=David+J.+Jeffries&amp;sortspec=date&amp;submit=Submit">David J. Jeffries</a></span><a id="xref-aff-3-3" class="xref-aff" href="#aff-3"><sup>†</sup></a>, 
                        </li>
                        <li class="contributor" id="contrib-7" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search" href="http://www.jimmunol.org/search?author1=Marianne+van+der+Sande&amp;sortspec=date&amp;submit=Submit">Marianne van der Sande</a></span><a id="xref-aff-3-4" class="xref-aff" href="#aff-3"><sup>†</sup></a>, 
                        </li>
                        <li class="contributor" id="contrib-8" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search" href="http://www.jimmunol.org/search?author1=Toyin+O.+Togun&amp;sortspec=date&amp;submit=Submit">Toyin O. Togun</a></span><a id="xref-aff-3-5" class="xref-aff" href="#aff-3"><sup>†</sup></a>, 
                        </li>
                        <li class="contributor" id="contrib-9" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search" href="http://www.jimmunol.org/search?author1=Samuel+J.+McConkey&amp;sortspec=date&amp;submit=Submit">Samuel J. McConkey</a></span><a id="xref-aff-3-6" class="xref-aff" href="#aff-3"><sup>†</sup></a>, 
                        </li>
                        <li class="contributor" id="contrib-10" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search" href="http://www.jimmunol.org/search?author1=Daniel+C.+Douek&amp;sortspec=date&amp;submit=Submit">Daniel C. Douek</a></span><a id="xref-aff-4-3" class="xref-aff" href="#aff-4"><sup>‡</sup></a>, 
                        </li>
                        <li class="contributor" id="contrib-11" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search" href="http://www.jimmunol.org/search?author1=Andrew+J.+McMichael&amp;sortspec=date&amp;submit=Submit">Andrew J. McMichael</a></span><a id="xref-aff-2-3" class="xref-aff" href="#aff-2"><sup>*</sup></a>, 
                        </li>
                        <li class="contributor" id="contrib-12" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search" href="http://www.jimmunol.org/search?author1=Hilton+C.+Whittle&amp;sortspec=date&amp;submit=Submit">Hilton C. Whittle</a></span><a id="xref-aff-3-7" class="xref-aff" href="#aff-3"><sup>†</sup></a>, 
                        </li>
                        <li class="contributor" id="contrib-13" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search" href="http://www.jimmunol.org/search?author1=Richard+A.+Koup&amp;sortspec=date&amp;submit=Submit">Richard A. Koup</a></span><a id="xref-aff-4-4" class="xref-aff" href="#aff-4"><sup>‡</sup></a> and 
                        </li>
                        <li class="last" id="contrib-14"><span class="name"><a class="name-search" href="http://www.jimmunol.org/search?author1=Sarah+L.+Rowland-Jones&amp;sortspec=date&amp;submit=Submit">Sarah L. Rowland-Jones</a></span><a id="xref-fn-3-1" class="xref-fn" href="#fn-3"><sup>2</sup></a><span class="xref-sep">,</span><a id="xref-aff-2-4" class="xref-aff" href="#aff-2"><sup>*</sup></a><span class="xref-sep">,</span><a id="xref-aff-3-8" class="xref-aff" href="#aff-3"><sup>†</sup></a></li>
                     </ol><p class="affiliation-list-reveal"><a href="#" class="view-more">+</a> Author Affiliations</p>
                     <ol class="affiliation-list hideaffil">
                        <li class="aff"><a id="aff-1" name="aff-1"></a><address></address>
                        </li>
                        <li class="aff"><a id="aff-2" name="aff-2"></a><address><sup>*</sup>Medical Research Council (MRC) Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, John
                              Radcliffe Hospital, Oxford, United Kingdom; 
                           </address>
                        </li>
                        <li class="aff"><a id="aff-3" name="aff-3"></a><address><sup>†</sup>MRC Laboratories Fajara, Banjul, The Gambia, West Africa; and 
                           </address>
                        </li>
                        <li class="aff"><a id="aff-4" name="aff-4"></a><address><sup>‡</sup>Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
                              20892
                           </address>
                        </li>
                     </ol>
                  </div>
                  <div class="section abstract" id="abstract-1" itemprop="description">
                     <div class="section-nav">
                        <div class="nav-placeholder">&nbsp;</div><a href="#intro-header" title="Introduction" class="next-section-link"><span>Next Section</span></a></div>
                     <h2>Abstract</h2>
                     
                     <p id="p-1">Unlike HIV-1-infected people, most HIV-2-infected subjects maintain a healthy CD4<sup>+</sup> T cell count and a strong HIV-specific CD4<sup>+</sup> T cell response. To define the cellular immunological correlates of good prognosis in HIV-2 infection, we conducted a cross-sectional
                        study of HIV Gag-specific T cell function in HIV-1- and HIV-2-infected Gambians. Using cytokine flow cytometry and lymphoproliferation
                        assays, we show that HIV-specific CD4<sup>+</sup> T cells from HIV-2-infected individuals maintained proliferative capacity, were not terminally differentiated (CD57<sup>−</sup>), and more frequently produced IFN-γ or IL-2 than CD4<sup>+</sup> T cells from HIV-1-infected donors. Polyfunctional (IFN-γ<sup>+</sup>/IL-2<sup>+</sup>) HIV-specific CD4<sup>+</sup> T cells were found exclusively in HIV-2<sup>+</sup> donors. The disparity in CD4<sup>+</sup> T cell responses between asymptomatic HIV-1- and HIV-2-infected subjects was not associated with differences in the proliferative
                        capacity of HIV-specific CD8<sup>+</sup> T cells. This study demonstrates that HIV-2-infected donors have a well-preserved and functionally heterogeneous HIV-specific
                        memory CD4<sup>+</sup> T cell response that is associated with delayed disease progression in the majority of infected people.
                     </p>
                     
                  </div>
                  <div id="intro-header">
                     <div class="section-nav"><a href="#abstract-1" title="Abstract" class="prev-section-link"><span>Previous Section</span></a><a href="#sec-1" title="Materials and Methods" class="next-section-link"><span>Next Section</span></a></div>
                     <h2 class="pre-section-content-header" id="introduction-text">Introduction</h2>
                  </div>
                  <p class="pre-section-content" id="p-2">The HIV-1 epidemic continues to spread worldwide, and an effective vaccine to prevent infection remains elusive. A major barrier
                     to HIV vaccine development is a limited understanding of the key components of protective immunity against HIV infection.
                     To define these components, considerable attention has been given to the minority of HIV-1-infected individuals who control
                     viral replication and remain asymptomatic for 10 years or more (<a id="xref-ref-1-1" class="xref-bibr" href="#ref-1">1</a>, <a id="xref-ref-2-1" class="xref-bibr" href="#ref-2">2</a>, <a id="xref-ref-3-1" class="xref-bibr" href="#ref-3">3</a>), so-called “long-term nonprogressors” (LTNPs),<a id="xref-fn-4-1" class="xref-fn" href="#fn-4"><sup>3</sup></a> who account for no more than 2–5% of HIV-1-infected cohorts. Fewer studies have addressed the relationship between the immune
                     response and control of viral replication with clinical outcome in HIV-2 infection. The clinical course of HIV-2 infection
                     is distinct from that of HIV-1. Despite a close phylogenetic relationship between the viruses, mortality rates are substantially
                     lower in HIV-2- than in HIV-1-infected populations (<a id="xref-ref-4-1" class="xref-bibr" href="#ref-4">4</a>, <a id="xref-ref-5-1" class="xref-bibr" href="#ref-5">5</a>). Although many HIV-2-infected individuals experience nonprogressive disease (<a id="xref-ref-4-2" class="xref-bibr" href="#ref-4">4</a>), a minority develop higher levels of plasma viral load and CD4<sup>+</sup> T cell decline (<a id="xref-ref-6-1" class="xref-bibr" href="#ref-6">6</a>), leading to an immunodeficiency syndrome indistinguishable from AIDS caused by HIV-1. Thus, most HIV-2-infected individuals
                     behave as LTNPs although in a minority of cases the virus is capable of causing profound immunodeficiency and death.
                  </p>
                  <p class="pre-section-content" id="p-3">Recent evidence suggests that many HIV-2 isolates are significantly less fit than group M HIV-1 isolates in terms of replicative
                     and transmission capacity (<a id="xref-ref-7-1" class="xref-bibr" href="#ref-7">7</a>). However, some HIV-2 isolates have been shown to replicate well in PBMC (<a id="xref-ref-7-2" class="xref-bibr" href="#ref-7">7</a>, <a id="xref-ref-8-1" class="xref-bibr" href="#ref-8">8</a>, <a id="xref-ref-9-1" class="xref-bibr" href="#ref-9">9</a>) and deplete CD4<sup>+</sup> T cells in ex vivo lymphoid tissue cultures (<a id="xref-ref-10-1" class="xref-bibr" href="#ref-10">10</a>). The proviral burden of HIV-2 is similar to that of HIV-1 in individuals at equivalent stages of disease (<a id="xref-ref-11-1" class="xref-bibr" href="#ref-11">11</a>, <a id="xref-ref-12-1" class="xref-bibr" href="#ref-12">12</a>, <a id="xref-ref-13-1" class="xref-bibr" href="#ref-13">13</a>). However, the plasma viral load is significantly lower in most HIV-2-infected individuals (<a id="xref-ref-14-1" class="xref-bibr" href="#ref-14">14</a>). This presumably contributes to substantially lower rates of vertical and horizontal HIV-2 transmission (<a id="xref-ref-15-1" class="xref-bibr" href="#ref-15">15</a>, <a id="xref-ref-16-1" class="xref-bibr" href="#ref-16">16</a>). Collectively, these data suggest that a different dynamic equilibrium of host and virus is established during HIV-2 infection,
                     raising the possibility that control of viral replication may in part be due to a more efficient host immune response to HIV-2
                     (<a id="xref-ref-17-1" class="xref-bibr" href="#ref-17">17</a>).
                  </p>
                  <p class="pre-section-content" id="p-4">Studies of the cellular immune response to HIV-2, though limited in number, have demonstrated vigorous HIV-2-specific cytotoxic
                     T cell responses in HIV-2-infected subjects (<a id="xref-ref-18-1" class="xref-bibr" href="#ref-18">18</a>, <a id="xref-ref-19-1" class="xref-bibr" href="#ref-19">19</a>). In addition, more recent studies have shown that HIV-1-and HIV-2-specific CD8<sup>+</sup> T cells have similar capacity to produce IFN-γ and proliferate (<a id="xref-ref-20-1" class="xref-bibr" href="#ref-20">20</a>, <a id="xref-ref-21-1" class="xref-bibr" href="#ref-21">21</a>), suggesting that enhanced viral control in HIV-2-infected people is not associated with these aspects of the virus-specific
                     CD8<sup>+</sup> T cell response. Although some HIV-2-infected individuals have been shown to mount a CD4<sup>+</sup> T cell response (<a id="xref-ref-22-1" class="xref-bibr" href="#ref-22">22</a>, <a id="xref-ref-23-1" class="xref-bibr" href="#ref-23">23</a>, <a id="xref-ref-24-1" class="xref-bibr" href="#ref-24">24</a>, <a id="xref-ref-25-1" class="xref-bibr" href="#ref-25">25</a>), there have been no studies to date investigating multiple functional and phenotypic parameters of HIV-2-specific CD4<sup>+</sup> T cells.
                  </p>
                  <p class="pre-section-content" id="p-5">In this study, we examined T cell immune responses to HIV-2 and HIV-1 in a well-characterized group of individuals attending
                     a clinic in The Gambia, West Africa (Table I<a id="xref-table-wrap-1-1" class="xref-down-link" href="#T1"><span>⇓</span></a>). In a cross-sectional analysis of 39 HIV-1<sup>+</sup> and 33 HIV-2<sup>+</sup> donors stratified by CD4<sup>+</sup> T cell count, we quantified the HIV-specific CD4<sup>+</sup> T cell response by intracellular cytokine staining (ICS) for IFN-γ and IL-2 and examined surface expression of CD57 for evidence
                     of terminal differentiation. In addition, we monitored the proliferative capacity of HIV-specific CD4<sup>+</sup> and CD8<sup>+</sup> T cells. We show that nonprogression in HIV-2 infection is associated with strong HIV-2-specific CD4<sup>+</sup> T cell responses, particularly a non-terminally differentiated, polyfunctional population of cytokine-producing cells with
                     preserved proliferative capacity.
                  </p>
                  <div class="table pos-float" id="T1">
                     <div class="table-inline">
                        <div class="callout"><span>View this table:</span><ul class="callout-links">
                              <li><a href="http://www.jimmunol.org/content/176/11/6973/T1.expansion.html">In this window</a></li>
                              <li><a target="_top" class="in-nw-vis" href="http://www.jimmunol.org/content/176/11/6973/T1.expansion.html">In a new window</a></li>
                           </ul>
                        </div>
                     </div>
                     <div class="table-caption"><span class="table-label">Table I.</span> 
                        
                        <p id="p-41" class="first-child">
                           <em>Clinical and demographic characteristics of study cohort<sup>a</sup></em>
                           
                        </p>
                        
                        <div class="sb-div caption-clear"></div>
                     </div>
                  </div>
                  <div class="section" id="sec-1">
                     <div class="section-nav"><a href="#intro-header" title="Introduction" class="prev-section-link"><span>Previous Section</span></a><a href="#sec-8" title="Results" class="next-section-link"><span>Next Section</span></a></div>
                     
                     <h2>Materials and Methods</h2>
                     
                     <div id="sec-2" class="subsection">
                        
                        <h3>Study population</h3>
                        
                        <p id="p-6">This study was conducted at the Medical Research Council (MRC) Laboratories in Fajara, The Gambia, West Africa. A total of
                           72 HIV-infected individuals, 39 HIV-1<sup>+</sup> and 33 HIV-2<sup>+</sup>, was recruited from the clinical HIV cohort attending the Genitourinary Medicine Clinic based at the MRC Unit. Additionally,
                           21 confirmed HIV-seronegative blood donors were recruited from the National Blood Bank at the Royal Victoria Teaching Hospital
                           in Banjul, The Gambia. As antiretroviral therapy (ART) was not available in The Gambia until recently, all study subjects
                           in this study were untreated. All individuals recruited for this study were infected with either HIV-2 or HIV-1 and were seronegative
                           for the other virus. Individuals with dual HIV-1<sup>+</sup>HIV-2<sup>+</sup> infection were excluded from the study. For analysis, study subjects were stratified into three categories based on CD4<sup>+</sup> T cell percentage rather than absolute CD4 count as this has proven to be a more reliable indicator of HIV-induced lymphopenia
                           and mortality in the developing world (<a id="xref-ref-20-2" class="xref-bibr" href="#ref-20">20</a>, <a id="xref-ref-26-1" class="xref-bibr" href="#ref-26">26</a>, <a id="xref-ref-27-1" class="xref-bibr" href="#ref-27">27</a>). These stratifications included individuals with a CD4 percentage (CD4%) within the normal range (CD4% ≥28), symptomatic
                           individuals who had an intermediate CD4% (CD4% = 14–27), and those individuals with clinical AIDS with a CD4% &lt;14%. Percentages
                           of CD4<sup>+</sup> T lymphocytes were determined by flow cytometry using BD MultiTest reagents and MultiSet software (BD Immunocytometry Systems).
                           Patients’ characteristics are detailed in Table I<a id="xref-table-wrap-1-2" class="xref-up-link" href="#T1"><span>⇑</span></a>. Study participants were screened for HIV-1 and HIV-2 using the Murex ICE HIV-1.2.0 capture enzyme immunoassay (Murex Diagnostics).
                           All reactive samples were confirmed as HIV-1 or HIV-2 positive using two type-specific competitive ELISAs (Murex Diagnostics).
                           HIV-1 and HIV-2 plasma viral loads were measured by an in-house reverse-transcriptase PCR assay using specific long terminal
                           repeat primers (<a id="xref-ref-28-1" class="xref-bibr" href="#ref-28">28</a>). The lower limit of detection for viral load assays was 100 RNA copies/ml. Samples with PCR signals below the level of detection
                           were assigned a viral load value of 100 RNA copies/ml. HIV-1-infected individuals consistently had a greater mean plasma viral
                           load than HIV-2-infected individuals at CD4 count &gt;14%, however, HIV-2-infected individuals at highly advanced stages of disease
                           had a higher mean plasma viral load than HIV-1-infected AIDS patients (Table I<a id="xref-table-wrap-1-3" class="xref-up-link" href="#T1"><span>⇑</span></a>). This is likely due to the small number of HIV-2-infected individuals with advanced disease and is likely inflated by two
                           individuals with very high viral loads, &gt;300,000 copies/ml. Additionally, HIV-2 viral load has been shown to increase during
                           <em>Plasmodium falciparum</em> infection in parasitemic individuals (<a id="xref-ref-29-1" class="xref-bibr" href="#ref-29">29</a>) and concomitant malaria infection cannot be ruled out as a cause of high viral load in these HIV-2-infected individuals.
                           Ethical approval was obtained from the Gambian Government/MRC Ethics Committee and each study participant gave informed consent
                           before entry into the study.
                        </p>
                        
                     </div>
                     
                     <div id="sec-3" class="subsection">
                        
                        <h3>Synthetic peptides</h3>
                        
                        <p id="p-7">Twenty-mer peptides overlapping by 10 aa corresponding to Gag sequences (p17 and p24) of the HIV-2 subtype A consensus and
                           HIV-1 clade A consensus strains were synthesized as free amino acids (HIV-2 (Affiniti); HIV-1 (NIBSC); &gt;85% purity by HPLC).
                           Previous studies have shown that the majority of HIV-1 infections in The Gambia are CRF-02, an A/G recombinant strain of which
                           the <em>gag</em> gene is subtype A (<a id="xref-ref-30-1" class="xref-bibr" href="#ref-30">30</a>, <a id="xref-ref-31-1" class="xref-bibr" href="#ref-31">31</a>), and HIV-2 infections are with subtype A virus (<a id="xref-ref-32-1" class="xref-bibr" href="#ref-32">32</a>). Lyophilized peptides were resuspended in DMSO (Sigma-Aldrich) at 50 mg/ml. The overlapping 20 mer were grouped into an
                           HIV-1 Gag pool (33 peptides) and an HIV-2 Gag pool (37 peptides) such that the concentration of each peptide in the pool was
                           400 μg/ml. Small aliquots of the Gag peptide pool mixtures were stored at −80°C and peptides were used at a final concentration
                           of 2 μg/ml/peptide in all experiments.
                        </p>
                        
                     </div>
                     
                     <div id="sec-4" class="subsection">
                        
                        <h3>Monoclonal Abs and flow cytometric analysis</h3>
                        
                        <p id="p-8">FITC, CFSE, PE, PerCP, and allophycocyanin were used as the fluorophores for these experiments. Unconjugated anti-human CD28
                           and anti-human CD49d were used as costimulatory Abs. mAbs used for the ICS assay were anti-CD57 FITC, anti-IL-2 PE, anti-CD4
                           PerCP, and anti-IFN-γ allophycocyanin (BD Pharmingen). CFSE (Molecular Probes), anti-CD8 PE, anti-CD3 PerCP, and anti-CD4
                           allophycocyanin (BD Biosciences) were used for characterization of T cell proliferative responses. Four-parameter flow cytometric
                           analysis was performed using a FACSCalibur flow cytometer (BD Biosciences). The list-mode data files were analyzed using FlowJo
                           (Tree Star).
                        </p>
                        
                     </div>
                     
                     <div id="sec-5" class="subsection">
                        
                        <h3>ICS for production of IFN-γ and IL-2 by HIV-specific CD4<sup>+</sup> T cells
                        </h3>
                        
                        <p id="p-9">Ten to 15 ml of peripheral blood was collected via venipuncture and PBMC were isolated using Ficoll-Hypaque (Pharmacia) density
                           centrifugation. This assay was performed only on freshly isolated PBMC and stimulation was performed as previously described
                           (<a id="xref-ref-33-1" class="xref-bibr" href="#ref-33">33</a>). Briefly, PBMC were resuspended at 10<sup>6</sup>/ml in RPMI medium supplemented with 10% heat-inactivated FCS and 1 μg/ml anti-CD28 and anti-CD49d costimulatory Abs. Due
                           to restrictions on the number of PBMCs recovered from the small volume of venipuncture, this study was restricted to the study
                           of HIV Gag-specific responses as this protein has been shown to be highly immunodominant in both HIV-1- and HIV-2-infected
                           individuals (<a id="xref-ref-25-2" class="xref-bibr" href="#ref-25">25</a>, <a id="xref-ref-34-1" class="xref-bibr" href="#ref-34">34</a>, <a id="xref-ref-35-1" class="xref-bibr" href="#ref-35">35</a>). Synthetic overlapping Gag peptide pools (final concentration 2 μg/ml/peptide) were used to stimulated HIV-specific responses.
                           HIV-1 or HIV-2 Gag peptide pools were used according to the status of the individual. These viruses share 60% amino acid homology
                           in the Gag region (<a id="xref-ref-36-1" class="xref-bibr" href="#ref-36">36</a>). For each individual, a negative control containing only anti-CD28 and anti-CD49d was used to measure Ag-independent stimulation
                           and a positive control staphylococcal enterotoxin B (SEB; final concentration 2 μg/ml) was used to ensure that cells were
                           responsive. The cultures were incubated for 1 h at 37°C in a 5% CO<sub>2</sub> incubator, followed by an additional 5 h in the presence of Brefeldin A (10 μg/ml; Sigma-Aldrich). Stimulated cells were
                           washed, fixed/permeabilized (FACSPerm2; BD Biosciences), and stained for surface markers and cytokines of interest. Cells
                           were then washed and resuspended in 2% paraformaldehyde in PBS for flow cytometric analysis. Responses are reported after
                           background correction, using the anti-CD28/49d-negative control to define nonspecific responses. A threshold of 0.1% was used
                           to define a positive HIV Gag-specific CD4<sup>+</sup> T cell response because no negative control sample showed nonspecific responses above this level and HIV Gag peptides did
                           not induce this level of nonspecific cytokine production in seronegative donors.
                        </p>
                        
                     </div>
                     
                     <div id="sec-6" class="subsection">
                        
                        <h3>CD4<sup>+</sup> and CD8<sup>+</sup> T cell CFSE proliferation assay
                        </h3>
                        
                        <p id="p-10">Briefly, freshly isolated PBMC or freshly thawed cryopreserved samples rested overnight were resuspended in PBS at a concentration
                           of 1–2 × 10<sup>6</sup>/ml. Cells were stained with CFSE (final concentration 0.25 μM; Molecular Probes) for 7 min in a 37°C water bath. CFSE labeling
                           was then quenched with 3 ml of FCS and cells were washed three times with RPMI supplemented with 10% FCS. CFSE-labeled PBMC
                           were resuspended at a final concentration of 1–2 × 10<sup>6</sup>/ml in RPMI supplemented with 10% human AB serum (Sigma-Aldrich) and 1 μg/ml anti-CD28 and anti-CD49d costimulatory Abs for
                           culture. PBMCs from each individual were then stimulated with overlapping Gag peptide pools (2 μg/ml/peptide), SEB (2 μg/ml),
                           or anti-CD28 and anti-CD49d alone (1 μg/ml each) and cultured at a concentration of 1–2 × 10<sup>6</sup> PBMC in a volume of 1 ml in 48-well plates (Nunc) at 37°C for 5 days. PBMC were then collected and stained for surface markers
                           of interest and fixed with 2% paraformaldehyde in PBS. CFSE-labeled cells were kept free from excessive light to avoid photobleaching
                           and were analyzed by flow cytometry within 24 h of staining. Percentages of total CD4<sup>+</sup> or CD8<sup>+</sup> T cells that divided in response to Gag peptide stimulation were calculated using the proliferation platform of FlowJo. Values
                           for Ag-specific responses are reported as the percent divided after subtraction of background proliferation in the unstimulated
                           samples.
                        </p>
                        
                     </div>
                     
                     <div id="sec-7" class="subsection">
                        
                        <h3>Statistical analysis</h3>
                        
                        <p id="p-11">Statistical tests were performed using two-tailed χ<sup>2</sup> analysis, Fisher’s exact test, two-sided ANOVA, Mann-Whitney <em>U</em> test, and Spearman rank correlations using GraphPad Prism 4.0a software and GenStat. Values of <em>p</em> were corrected for multiple comparisons and differences were considered statistically significant when <em>p</em> &lt; 0.05 after correction.
                        </p>
                        
                     </div>
                     
                  </div>
                  <div class="section" id="sec-8">
                     <div class="section-nav"><a href="#sec-1" title="Materials and Methods" class="prev-section-link"><span>Previous Section</span></a><a href="#sec-16" title="Discussion" class="next-section-link"><span>Next Section</span></a></div>
                     
                     <h2>Results</h2>
                     
                     <div id="sec-9" class="subsection">
                        
                        <h3>More HIV-2- than HIV-1-infected subjects have detectable HIV Gag-specific CD4<sup>+</sup> T cells
                        </h3>
                        
                        <p id="p-12">ICS was used to monitor production of IFN-γ and IL-2 by Ag-specific CD4<sup>+</sup> T cells. Although HIV Gag-specific CD4<sup>+</sup> T cell responses were observed in the majority of both HIV-1- and HIV-2-infected subjects, more HIV-2-infected (85%; 28 of
                           33) than HIV-1-infected individuals (64%; 25 of 39) had CD4<sup>+</sup> T cells producing IFN-γ in response to their respective Gag peptide pools (<em>p</em> = 0.04; Table II<a id="xref-table-wrap-2-1" class="xref-down-link" href="#T2"><span>⇓</span></a>). The difference was more marked for IL-2-producing CD4<sup>+</sup> T cells, which were detected in 64% of HIV-2-infected compared with 36% of HIV-1-infected individuals (<em>p</em> = 0.01). Interestingly, among individuals with a relatively preserved CD4<sup>+</sup> T cell count (&gt;28%) 94% (16 of 17) of HIV-2-infected individuals had detectable IFN-γ-producing CD4<sup>+</sup> T cells, and 53% (9 of 17) had detectable IL-2-producing CD4<sup>+</sup> T cells. In contrast, 64% (7 of 11) of asymptomatic HIV-1-infected individuals had detectable IFN-γ-producing CD4<sup>+</sup> T cells, while only 9% (1 of 11) had IL-2-producing CD4<sup>+</sup> T cells (Table II<a id="xref-table-wrap-2-2" class="xref-down-link" href="#T2"><span>⇓</span></a>).
                        </p>
                        <div class="table pos-float" id="T2">
                           <div class="table-inline">
                              <div class="callout"><span>View this table:</span><ul class="callout-links">
                                    <li><a href="http://www.jimmunol.org/content/176/11/6973/T2.expansion.html">In this window</a></li>
                                    <li><a target="_top" class="in-nw-vis" href="http://www.jimmunol.org/content/176/11/6973/T2.expansion.html">In a new window</a></li>
                                 </ul>
                              </div>
                           </div>
                           <div class="table-caption"><span class="table-label">Table II.</span> 
                              
                              <p id="p-45" class="first-child">
                                 <em>Proportion of HIV-1- and HIV-2-infected individuals with CD4<sup>+</sup> T cells producing IFN-γ or IL-2 in response to HIV Gag peptides<sup>a</sup></em>
                                 
                              </p>
                              
                              <div class="sb-div caption-clear"></div>
                           </div>
                        </div>
                        
                     </div>
                     
                     <div id="sec-10" class="subsection">
                        
                        <h3>HIV-2-infected donors have higher frequencies of HIV-specific CD4<sup>+</sup> T cells than HIV-1-infected donors
                        </h3>
                        
                        <p id="p-13">We quantified the frequency of CD4<sup>+</sup> T cells producing IFN-γ only, IL-2 only, or both IFN-γ and IL-2 in response to stimulation with overlapping Gag peptides
                           using flow cytometry (representative flow cytometric plots are shown in Fig. 1<a id="xref-fig-1-1" class="xref-down-link" href="#F1"><span>⇓</span></a><em>a</em>). In donors with relatively preserved CD4<sup>+</sup> T cell counts (≥28%), a greater proportion of total CD4<sup>+</sup> T cells from HIV-2-infected subjects produced IFN-γ in response to Gag peptides than from HIV-1-infected subjects (median
                           0.315 vs 0.130%; <em>p</em> = 0.014) (Fig. 1<a id="xref-fig-1-2" class="xref-down-link" href="#F1"><span>⇓</span></a><em>b</em>). Additionally, the frequency of IL-2-producing HIV-specific CD4<sup>+</sup> T cells was significantly greater in HIV-2-infected individuals with preserved CD4<sup>+</sup> T cell counts (median 0.068%) than in CD4-matched HIV-1-infected individuals (median 0.012%; <em>p</em> = 0.0077) (Fig. 1<a id="xref-fig-1-3" class="xref-down-link" href="#F1"><span>⇓</span></a><em>c</em>). The differences in HIV-specific CD4<sup>+</sup> T cell responses between HIV-1- and HIV-2-infected subjects were less obvious in donors with intermediate CD4<sup>+</sup> T cell counts (CD4% = 14–27) and were absent in donors with CD4% &lt;14 (Fig. 1<a id="xref-fig-1-4" class="xref-down-link" href="#F1"><span>⇓</span></a>, <em>b</em> and <em>c</em>). CD4<sup>+</sup> T cell responses to the superantigen SEB did not differ between any group of HIV-1- and HIV-2-infected individuals (data
                           not shown) and control experiments in HIV-seronegative blood donors demonstrated that HIV Gag peptides induced &lt;0.1% of total
                           CD4<sup>+</sup> T cells to produce either IFN-γ or IL-2.
                        </p>
                        <div id="F1" class="fig pos-float odd">
                           <div class="fig-inline"><a class="fig-inline-link" href="http://www.jimmunol.org/content/176/11/6973/F1.expansion.html"><img alt="  FIGURE 1. " src="F1.small.gif"></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                                    <li><a class="fig-inline-link" href="http://www.jimmunol.org/content/176/11/6973/F1.expansion.html">In this page</a></li>
                                    <li><a target="_top" class="in-nw-vis" href="http://www.jimmunol.org/content/176/11/6973/F1.expansion.html">In a new window</a></li>
                                 </ul>
                                 <ul class="fig-services"></ul>
                              </div>
                           </div>
                           <div class="fig-caption"><span class="fig-label">

                                 FIGURE 1.
                                 </span> 
                              
                              <p id="p-37" class="first-child">Functional flow cytometric analysis of HIV-1 and HIV-2 Gag-specific CD4<sup>+</sup> T cell response. <em>a</em>, Representative FACS plots from asymptomatic HIV-1 (<em>top row</em>) and HIV-2 (<em>bottom row</em>) subjects, both with CD4<sup>+</sup> T cell percentages ≥28%. The flow cytometric data represent gated CD4<sup>+</sup> T cells and are demonstrated as follows: background (costimulatory Abs alone, <em>left column</em>); HIV Ag-specific (Gag peptide pool, <em>center column</em>); and polyclonal positive control (SEB, <em>right column</em>). <em>y</em>-axis represents staining for IL-2 and <em>x</em>-axis is staining for IFN-γ. The numbers in each quadrant indicate the percentage of CD4<sup>+</sup> T cells that produced either IFN-γ alone (<em>bottom right quadrant</em>), IL-2 alone (<em>upper left quadrant</em>), or both IFN-γ and IL-2 (<em>upper right quadrant</em>) in response to stimulus. Scatter plots show the proportion of CD4<sup>+</sup> T cells producing IFN-γ (<em>b</em>) IL-2 (<em>c</em>) or both IFN-γ and IL-2 (<em>d</em>) in HIV-2 ( <img class="inline-graphic" alt="Graphic" src="inline-graphic-1.gif">), HIV-1 ( <img class="inline-graphic" alt="Graphic" src="inline-graphic-2.gif">), or HIV-negative (▵) donors in response to pooled Gag peptides. Median value in each category is delineated with a horizontal
                                 bar and represents total Ag-specific responses above background. A dotted line at 0.1% response indicates the level above
                                 which responses are considered to be positive. Data were log-transformed for analysis and statistical significance was determined
                                 using ANOVA and adjusted for multiplicity using the Holm step-down method.
                              </p>
                              
                              <div class="sb-div caption-clear"></div>
                           </div>
                        </div>
                        
                        <p id="p-14">Overall, the frequency of cytokine-producing HIV-specific CD4<sup>+</sup> T cells was far greater in HIV-2<sup>+</sup> individuals with preserved CD4<sup>+</sup> T cell counts than in HIV-1<sup>+</sup> individuals with comparable CD4<sup>+</sup> T cell counts; individuals infected with HIV-2 had a 2.4-fold higher median frequency of IFN-γ-producing CD4<sup>+</sup> T cells, and a 5.7-fold higher median frequency of IL-2-producing CD4<sup>+</sup> T cells, when stimulated with their respective Gag peptide pools. These trends were the same when individuals were stratified
                           by absolute CD4 count rather than by CD4%. Significantly greater frequencies of IFN-γ- or IL-2-producing HIV-specific CD4<sup>+</sup> T cells were found among HIV-2-infected individuals with an absolute CD4 count ≥500 cells/ml compared with CD4-matched HIV-1-infected
                           individuals (data not shown). These findings indicate that asymptomatic HIV-2<sup>+</sup> individuals maintain a more substantial HIV-specific memory CD4<sup>+</sup> T cell response than HIV-1<sup>+</sup> subjects.
                        </p>
                        
                     </div>
                     
                     <div id="sec-11" class="subsection">
                        
                        <h3>HIV-specific CD4<sup>+</sup> T cells producing both IFN-γ and IL-2 are detected exclusively in HIV-2-infected individuals
                        </h3>
                        
                        <p id="p-15">HIV-specific CD4<sup>+</sup> T cells that produced both IFN-γ and IL-2 in response to HIV Gag peptides were detected at a frequency of &gt;0.1% in 36% (12
                           of 33) of HIV-2<sup>+</sup> subjects, predominantly among individuals with a normal CD4<sup>+</sup> T cell percentage (Fig. 1<a id="xref-fig-1-5" class="xref-up-link" href="#F1"><span>⇑</span></a>, <em>a</em> and <em>d</em>). This population of CD4<sup>+</sup> T cells made a substantial contribution to the total HIV-2 Gag-specific CD4<sup>+</sup> T cell response, accounting for ∼17% of the response irrespective of CD4<sup>+</sup> T cell count (Fig. 2<a id="xref-fig-2-1" class="xref-down-link" href="#F2"><span>⇓</span></a><em>a</em>). In contrast, this dual cytokine-producing population of HIV-specific CD4<sup>+</sup> T cells was absent (&lt;0.1%) from all 39 HIV-1-infected individuals we studied (Figs. 1<a id="xref-fig-1-6" class="xref-up-link" href="#F1"><span>⇑</span></a>, <em>a</em> and <em>d</em>, and 2<em>b</em>). In our cohort of HIV-1-infected donors, HIV-1-specific CD4<sup>+</sup> T cells responded to Gag peptides by producing either IFN-γ or IL-2, but not both.
                        </p>
                        <div id="F2" class="fig pos-float odd">
                           <div class="fig-inline"><a class="fig-inline-link" href="http://www.jimmunol.org/content/176/11/6973/F2.expansion.html"><img alt="  FIGURE 2. " src="F2.small.gif"></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                                    <li><a class="fig-inline-link" href="http://www.jimmunol.org/content/176/11/6973/F2.expansion.html">In this page</a></li>
                                    <li><a target="_top" class="in-nw-vis" href="http://www.jimmunol.org/content/176/11/6973/F2.expansion.html">In a new window</a></li>
                                 </ul>
                                 <ul class="fig-services"></ul>
                              </div>
                           </div>
                           <div class="fig-caption"><span class="fig-label">

                                 FIGURE 2.
                                 </span> 
                              
                              <p id="p-38" class="first-child">Functional heterogeneity of HIV-2-specific CD4<sup>+</sup> T cell cytokine profile. Stacked graphs show percentage of CD4<sup>+</sup> T cells that produced IFN-γ only (black), IL-2 only (gray), or both IFN-γ and IL-2 (striped) in response to pooled Gag peptides
                                 in the 6-h assay in HIV-2 (<em>a</em>) and HIV-1 (<em>b</em>) infected individuals. A column composed of these three segments represents each individual’s response. Ag-specific responses
                                 above 0.1% of total CD4<sup>+</sup> T cells producing each cytokine were considered a positive response. Total IFN-γ production is the combined black and striped
                                 segments. Total IL-2 production is the combination of the gray and striped segments. Vertical lines stratify patients based
                                 on CD4<sup>+</sup> T cell percentage and pie charts depict the mean proportion of the total HIV-specific response contributed by each cytokine
                                 population in each stratified category.
                              </p>
                              
                              <div class="sb-div caption-clear"></div>
                           </div>
                        </div>
                        
                        <p id="p-16">Those HIV-2-infected individuals with strong CD4<sup>+</sup> T cell responses to HIV-2 Gag peptides had high frequencies of CD4<sup>+</sup> T cells in all three functional populations: IFN-γ only, IL-2 only, and polyfunctional IFN-γ<sup>+</sup>IL-2<sup>+</sup>. There was a strong correlation between the frequency of CD4<sup>+</sup> T cells producing only IFN-γ and those CD4<sup>+</sup> T cells producing IL-2 alone (<em>R</em> = 0.43, <em>p</em> = 0.01; data not shown). There was also a very strong correlation between the frequency of polyfunctional IFN-γ<sup>+</sup>IL-2<sup>+</sup>CD4<sup>+</sup> T cells and the frequency of IFN-γ only (<em>R</em> = 0.69, <em>p</em> &lt; 0.0001) or IL-2 only producing CD4<sup>+</sup> T cells (<em>R</em> = 0.47, <em>p</em> = 0.005; data not shown). This suggests that the CD4<sup>+</sup> T cell response to HIV-2 is indeed functionally heterogeneous and individuals with strong responses tend to have a total
                           CD4<sup>+</sup> T cell response to the virus that is a compilation of at least three functionally distinct cytokine-producing populations.
                        </p>
                        
                     </div>
                     
                     <div id="sec-12" class="subsection">
                        
                        <h3>The increase in HIV-specific CD4<sup>+</sup> T cells in HIV-2 infection is due to the presence of CD4<sup>+</sup> T cells lacking CD57 expression
                        </h3>
                        
                        <p id="p-17">An important function of CD4<sup>+</sup> T cells is their ability to proliferate in response to cognate Ag stimulation. Surface expression of CD57 is associated with
                           the inability to proliferate and indicates terminal differentiation (<a id="xref-ref-37-1" class="xref-bibr" href="#ref-37">37</a>). To determine whether the higher frequency of HIV-specific CD4<sup>+</sup> T cells in HIV-2-infected individuals was among the terminally differentiated (CD57<sup>+</sup>) or non-terminally differentiated (CD57<sup>−</sup>) fraction, we measured CD57 expression on the HIV-1- and HIV-2-specific cytokine-producing CD4<sup>+</sup> T cells. We found that the increase in HIV-specific cytokine-producing CD4<sup>+</sup> T cells in HIV-2<sup>+</sup> as compared with HIV-1<sup>+</sup> subjects with preserved CD4<sup>+</sup> T cell counts was predominantly within the CD57<sup>−</sup> fraction (<em>p</em> = 0.01, Fig. 3<a id="xref-fig-3-1" class="xref-down-link" href="#F3"><span>⇓</span></a><em>b</em>). There was no difference in the frequency of CD57<sup>+</sup> HIV-specific, cytokine-producing CD4<sup>+</sup> T cells among HIV-1- or HIV-2 infected individuals at any stage of disease (Fig. 3<a id="xref-fig-3-2" class="xref-down-link" href="#F3"><span>⇓</span></a><em>a</em>). These data indicate that the increase in HIV-2-specific CD4<sup>+</sup> T cells is predominantly made up of CD57<sup>−</sup> cells, which likely retain proliferative capacity.
                        </p>
                        <div id="F3" class="fig pos-float odd">
                           <div class="fig-inline"><a class="fig-inline-link" href="http://www.jimmunol.org/content/176/11/6973/F3.expansion.html"><img alt="  FIGURE 3. " src="F3.small.gif"></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                                    <li><a class="fig-inline-link" href="http://www.jimmunol.org/content/176/11/6973/F3.expansion.html">In this page</a></li>
                                    <li><a target="_top" class="in-nw-vis" href="http://www.jimmunol.org/content/176/11/6973/F3.expansion.html">In a new window</a></li>
                                 </ul>
                                 <ul class="fig-services"></ul>
                              </div>
                           </div>
                           <div class="fig-caption"><span class="fig-label">

                                 FIGURE 3.
                                 </span> 
                              
                              <p id="p-39" class="first-child">CD57 expression on HIV-specific CD4<sup>+</sup> T cells. Scatter plots show the proportion of total CD4<sup>+</sup> T cells that produced cytokine (IFN-γ<sup>+</sup>, IL-2<sup>+</sup>, or IFN-γ<sup>+</sup>IL-2<sup>+</sup>) in response to pooled Gag peptides and express (<em>a</em>) or lack (<em>b</em>) cell surface expression of CD57 in HIV-2 ( <img class="inline-graphic" alt="Graphic" src="inline-graphic-3.gif">) and HIV-1 (•) donors. Median value in each category is delineated with a horizontal line. Values of <em>p</em> were generated using two-tailed Mann-Whitney <em>U</em> test. Bar graphs depict the proportion of the total HIV-2-specific CD57<sup>+</sup>CD4<sup>+</sup> (<em>c</em>) or CD57<sup>−</sup>CD4<sup>+</sup> (<em>d</em>) response contributed by IFN-γ<sup>+</sup> (▪), IL-2<sup>+</sup> ( <img class="inline-graphic" alt="Graphic" src="inline-graphic-4.gif">) or IFN-γ<sup>+</sup>IL-2<sup>+</sup> (▤) populations in four HIV-2<sup>+</sup> individuals with the percentage of CD4<sup>+</sup>cytokine<sup>+</sup>CD57<sup>+</sup> &gt;0.28%. Mean and SDs are shown.
                              </p>
                              
                              <div class="sb-div caption-clear"></div>
                           </div>
                        </div>
                        
                        <p id="p-18">Interestingly, HIV-2-specific CD4<sup>+</sup> T cells that expressed CD57 were skewed toward IFN-γ-producing populations, with a mean 77% of the Gag-responsive CD4<sup>+</sup> T cells producing IFN-γ alone (Fig. 3<a id="xref-fig-3-3" class="xref-up-link" href="#F3"><span>⇑</span></a><em>c</em>). HIV-2-specific CD4<sup>+</sup> T cells lacking CD57 expression were more polyfunctional in nature, with a greater percentage of CD4<sup>+</sup> T cells producing IL-2 in response to Gag peptides (Fig. 3<a id="xref-fig-3-4" class="xref-up-link" href="#F3"><span>⇑</span></a><em>d</em>).
                        </p>
                        
                     </div>
                     
                     <div id="sec-13" class="subsection">
                        
                        <h3>Superior proliferative capacity of HIV-2-specific CD4<sup>+</sup> T cells
                        </h3>
                        
                        <p id="p-19">Ag-specific CD4<sup>+</sup> T cell proliferation has been regarded as a major indicator of functional CD4<sup>+</sup> T cell help. We used the CFSE-based lymphoproliferation assay to monitor CD4<sup>+</sup> and CD8<sup>+</sup> T cell proliferative capacity in response to HIV Gag peptides in HIV-1<sup>+</sup> and HIV-2<sup>+</sup> study participants. Fresh PBMC from 14 HIV-1- and 18 HIV-2-infected individuals were isolated from a venipuncture 5–10 mo
                           after the original time point. For those individuals who were lost to follow-up, we used frozen PBMC samples where available
                           (14 HIV-1 and 8 HIV-2 samples collected between 16 mo before and 8 mo after the original time point). We could not complete
                           the study for 11 of 39 HIV-1-and 7 of 33 HIV-2-infected individuals from our original cohort for whom there were no frozen
                           historical samples.
                        </p>
                        
                        <p id="p-20">Fresh or frozen PBMC were stimulated with Gag peptides, SEB, or costimulatory Abs alone for 5 days and proliferative responses
                           were measured in the CD3<sup>+</sup>CD4<sup>+</sup> and CD3<sup>+</sup>CD8<sup>+</sup> T cell subsets (representative flow plots are shown in Fig. 4<a id="xref-fig-4-1" class="xref-down-link" href="#F4"><span>⇓</span></a><em>a</em>). Stimulation of PBMC from HIV-2-infected individuals with normal CD4<sup>+</sup> T cell percentages (≥28%) with HIV-2 Gag peptides induced the proliferation of a median 0.6% of total CD4<sup>+</sup> T cells over 5 days (range 0.0–3.1%; Fig. 4<a id="xref-fig-4-2" class="xref-down-link" href="#F4"><span>⇓</span></a><em>b</em>). In striking contrast, we observed a profoundly attenuated proliferative response in CD4<sup>+</sup> T cells from HIV-1-infected individuals with comparable CD4<sup>+</sup> T cell percentages. In these subjects, a median 0.2% of total peripheral blood CD4<sup>+</sup> T cells expanded in response to HIV-1 Gag peptides over 5 days (range 0.02–0.40%; <em>p</em> = 0.03). These differences were also apparent when subjects were stratified by absolute CD4 count (data not shown). Thus,
                           the proliferative capacity of HIV-2-specific CD4<sup>+</sup> T cells among individuals with normal CD4<sup>+</sup> T cell counts was 3-fold greater than that of CD4-matched HIV-1-infected individuals. This difference was not observed in
                           individuals with CD4<sup>+</sup> T cell percentage below the normal range (&lt;28%) where proliferative responses in both HIV-1- and HIV-2-infected individuals
                           were diminished.
                        </p>
                        <div id="F4" class="fig pos-float odd">
                           <div class="fig-inline"><a class="fig-inline-link" href="http://www.jimmunol.org/content/176/11/6973/F4.expansion.html"><img alt="  FIGURE 4. " src="F4.small.gif"></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                                    <li><a class="fig-inline-link" href="http://www.jimmunol.org/content/176/11/6973/F4.expansion.html">In this page</a></li>
                                    <li><a target="_top" class="in-nw-vis" href="http://www.jimmunol.org/content/176/11/6973/F4.expansion.html">In a new window</a></li>
                                 </ul>
                                 <ul class="fig-services"></ul>
                              </div>
                           </div>
                           <div class="fig-caption"><span class="fig-label">

                                 FIGURE 4.
                                 </span> 
                              
                              <p id="p-40" class="first-child">Proliferative capacity of HIV-1 and HIV-2-specific CD4<sup>+</sup> and CD8<sup>+</sup> T cells. <em>a</em>, Representative flow cytometric plots from asymptomatic HIV-1 (<em>left</em>) and HIV-2 (<em>right</em>) subjects. The flow cytometric data represent gated CD3<sup>+</sup> live lymphocytes and demonstrate HIV-specific (Gag peptide pool, <em>top row</em>), SEB (<em>middle row</em>), and background (costimulatory Abs alone, <em>bottom row</em>) stimulation conditions. CD4<sup>+</sup> T cell responses are shown in first column, CD8<sup>+</sup> T cell responses in second column, and the <em>x</em>-axis is CFSE fluorescence. The numbers indicate the percentage of each population that has divided over 5 days. Scatter plots
                                 show proportion of CD4<sup>+</sup> T cells (<em>b</em>) or CD8<sup>+</sup> T cells (<em>c</em>) dividing in response to Gag peptides in HIV-2<sup>+</sup> ( <img class="inline-graphic" alt="Graphic" src="inline-graphic-5.gif">) or HIV-1<sup>+</sup> (•) donors. Median value in each category is delineated with a horizontal bar and represents total Ag-specific responses
                                 above background. Data were square-root transformed for analysis and statistical significance was determined using ANOVA.
                              </p>
                              
                              <div class="sb-div caption-clear"></div>
                           </div>
                        </div>
                        
                     </div>
                     
                     <div id="sec-14" class="subsection">
                        
                        <h3>No difference in the capacity of HIV-2- and HIV-1-specific CD8<sup>+</sup> T cells to proliferate
                        </h3>
                        
                        <p id="p-21">In contrast to the differences we observed in the proliferative capacity of HIV-specific CD4<sup>+</sup> T cells between HIV-1<sup>+</sup> and HIV-2<sup>+</sup> individuals, we found no differences in the ability of HIV Gag-specific CD8<sup>+</sup> T cells from HIV-1- and HIV-2-infected individuals to proliferate in response to type-specific HIV Gag peptides (Fig. 4<a id="xref-fig-4-3" class="xref-up-link" href="#F4"><span>⇑</span></a><em>c</em>). The median frequencies of responding CD8<sup>+</sup> T cells were similar among individuals with a normal CD4<sup>+</sup> percentage, with responses of 0.60% in HIV-2<sup>+</sup> subjects compared with 0.89% in HIV-1<sup>+</sup> donors (<em>p</em> = 0.34). The frequency of proliferating CD8<sup>+</sup> T cells decreased as CD4 counts declined in both HIV-1- and HIV-2-infected individuals, but the median frequencies still
                           did not differ significantly (0.17 vs 0.09%; <em>p</em> = 0.99).
                        </p>
                        
                     </div>
                     
                     <div id="sec-15" class="subsection">
                        
                        <h3>The frequency of polyfunctional IFN-γ<sup>+</sup>IL-2<sup>+</sup> CD4<sup>+</sup> T cells correlates with the proliferative capacity of HIV-2-specific CD4<sup>+</sup> and CD8<sup>+</sup> T cells
                        </h3>
                        
                        <p id="p-22">Previous studies have shown that HIV-1-infected individuals who fail to control viral load even in the presence of ART have
                           HIV-specific CD4<sup>+</sup> T cells that predominantly produce IFN-γ, and have a greatly diminished proliferative capacity (<a id="xref-ref-38-1" class="xref-bibr" href="#ref-38">38</a>, <a id="xref-ref-39-1" class="xref-bibr" href="#ref-39">39</a>). In contrast, we find that HIV-2<sup>+</sup> individuals have an expanded frequency of polyfunctional IFN-γ<sup>+</sup>IL-2<sup>+</sup>CD4<sup>+</sup> T cells which correlated with the proliferative capacity of both HIV-2-specific CD4<sup>+</sup> (<em>R</em> = 0.44, <em>p</em> = 0.02) and CD8<sup>+</sup> (<em>R</em> = 0.44, <em>p</em> = 0.02) T cells (data not shown). We also found that although HIV-2-infected individuals with a high frequency of HIV-specific
                           IFN-γ<sup>+</sup>IL-2<sup>+</sup>CD4<sup>+</sup> T cells tended to have low or undetectable plasma viral load, there was no correlation between these parameters (data not
                           shown).
                        </p>
                        
                     </div>
                     
                  </div>
                  <div class="section" id="sec-16">
                     <div class="section-nav"><a href="#sec-8" title="Results" class="prev-section-link"><span>Previous Section</span></a><a href="#sec-17" title="Acknowledgments" class="next-section-link"><span>Next Section</span></a></div>
                     
                     <h2>Discussion</h2>
                     
                     <p id="p-23">Although HIV-2 can, in a minority of infected individuals, cause AIDS indistinguishable from that caused by HIV-1, many HIV-2-infected
                        people behave as LTNPs. This provides a unique natural human model in which to investigate correlates of immune protection
                        against HIV disease progression. One of the characteristic immune defects in HIV-1 infection is the early loss of HIV-specific
                        CD4<sup>+</sup> T cells with proliferative capacity and the ability to secrete IL-2 (<a id="xref-ref-3-2" class="xref-bibr" href="#ref-3">3</a>, <a id="xref-ref-40-1" class="xref-bibr" href="#ref-40">40</a>), which leaves an impaired CD4<sup>+</sup> Th cell response that is skewed toward a population that produces IFN-γ only (<a id="xref-ref-33-2" class="xref-bibr" href="#ref-33">33</a>, <a id="xref-ref-39-2" class="xref-bibr" href="#ref-39">39</a>). Indeed, aside from a unique population of HIV-1-infected individuals who meet the definition of LTNPs and some patients
                        treated with highly active ART, HIV-specific CD4<sup>+</sup> T cell responses are conspicuously absent or impaired in HIV-1 infection, irrespective of viral load and CD4<sup>+</sup> T cell count (<a id="xref-ref-1-2" class="xref-bibr" href="#ref-1">1</a>, <a id="xref-ref-38-2" class="xref-bibr" href="#ref-38">38</a>, <a id="xref-ref-39-3" class="xref-bibr" href="#ref-39">39</a>). In this study, we demonstrate that HIV-2-infected subjects, especially those with preserved CD4<sup>+</sup> T cell counts, are distinct from HIV-1-infected individuals in that they maintain a proliferation-competent, nonterminally
                        differentiated, multiple cytokine-expressing HIV-specific CD4<sup>+</sup> T cell response.
                     </p>
                     
                     <p id="p-24">These findings extend previous studies that demonstrated preserved virus-specific proliferative responses in a small number
                        of HIV-2-infected individuals (<a id="xref-ref-23-2" class="xref-bibr" href="#ref-23">23</a>, <a id="xref-ref-24-2" class="xref-bibr" href="#ref-24">24</a>). Although a prior study has shown that the magnitude of the HIV Gag-specific IFN-γ response by ex vivo ELISPOT was not significantly
                        different in HIV-1- and HIV-2-infected donors (<a id="xref-ref-25-3" class="xref-bibr" href="#ref-25">25</a>), we found using ICS that the magnitude of CD4<sup>+</sup> T cells responding to HIV Gag peptides was much greater among HIV-2-infected individuals.
                     </p>
                     
                     <p id="p-25">HIV-specific CD4<sup>+</sup> Th cell function is reported to be impaired from the earliest stages of HIV-1 infection (<a id="xref-ref-40-2" class="xref-bibr" href="#ref-40">40</a>), in the absence of prompt treatment with ART (<a id="xref-ref-2-2" class="xref-bibr" href="#ref-2">2</a>), which may be explained by the preferential infection of HIV-1-specific CD4<sup>+</sup> T cells (<a id="xref-ref-41-1" class="xref-bibr" href="#ref-41">41</a>). The devastating impact of primary SIV infection on the CD4<sup>+</sup> T cell population in gut-associated lymphoid tissue, which accounts for the bulk of the body’s CD4<sup>+</sup> T cells, has recently been documented in animal models (<a id="xref-ref-42-1" class="xref-bibr" href="#ref-42">42</a>, <a id="xref-ref-43-1" class="xref-bibr" href="#ref-43">43</a>), and a similar phenomenon is likely to occur in human HIV-1 infection, in which gut-associated lymphoid tissue CD4<sup>+</sup> T cells are profoundly depleted even in primary HIV-1 infection (<a id="xref-ref-44-1" class="xref-bibr" href="#ref-44">44</a>, <a id="xref-ref-45-1" class="xref-bibr" href="#ref-45">45</a>). The preservation of virus-specific T cell help in many subjects with HIV-2 infection suggests that HIV-2 may not preferentially
                        infect or deplete HIV-2-specific cells in these subjects. Further studies to investigate whether HIV-2-specific CD4<sup>+</sup> T cells resist viral infection and, if so, by what mechanism are clearly warranted.
                     </p>
                     
                     <p id="p-26">The critical features of CD4<sup>+</sup> T cell help that contribute to protective immunity probably differ among viral infections, but recent studies in other chronic
                        viral infections have shown that Ag load and persistence dictate the functional profile of CD4<sup>+</sup> T cell responses, and that protective and effective responses, typified by those seen in CMV and EBV infections, are characterized
                        by the presence of CD4<sup>+</sup> T cells that produce both IFN-γ and IL-2 (<a id="xref-ref-46-1" class="xref-bibr" href="#ref-46">46</a>). In keeping with these observations, we find that maintenance of a normal CD4<sup>+</sup> T cell count in HIV-2 infection is associated with a population of polyfunctional IFN-γ<sup>+</sup>IL-2<sup>+</sup> HIV-specific CD4<sup>+</sup> T cells that was absent in all HIV-1-infected individuals in our cohort. This polyfunctional CD4<sup>+</sup> T cell population contributes substantially (17–18%) to the total HIV-2-specific CD4<sup>+</sup> T cell response and the magnitude of this population correlates with the ability of both HIV-2-specific CD4<sup>+</sup> and CD8<sup>+</sup> T cells to proliferate in vitro. In a cross-sectional study of this nature, it is not possible to determine whether preserved
                        CD4<sup>+</sup> T cell counts in the presence of virus-specific IFN-γ<sup>+</sup>IL-2<sup>+</sup>CD4<sup>+</sup> T cells is a cause or effect of this population. However, because this polyfunctional subset is found only among HIV-2-infected
                        individuals, and has been shown to be a hallmark of effective immunity in other viral infections, the presence of this subset
                        may be a contributing factor in the attenuated clinical phenotype of HIV-2 infection. Though polyfunctional IFN-γ<sup>+</sup>IL-2<sup>+</sup> HIV-1-specific CD4<sup>+</sup> T cells have been documented in rare HIV-1 LTNP (<a id="xref-ref-47-1" class="xref-bibr" href="#ref-47">47</a>), we did not detect them in our HIV-1-infected population which was not enriched for LTNP and may have predominantly comprised
                        donors with typical disease progression at an early stage of infection.
                     </p>
                     
                     <p id="p-27">Terminally differentiated CD57<sup>+</sup> T cells are often IFN-γ-producing effector cells (<a id="xref-ref-48-1" class="xref-bibr" href="#ref-48">48</a>) that lack proliferative capacity and die upon secondary stimulation (<a id="xref-ref-37-2" class="xref-bibr" href="#ref-37">37</a>). In mice, these IFN-γ-producing effector cells are not precursors of memory CD4<sup>+</sup> T cells, which instead make IL-2 and proliferate on secondary stimulation (<a id="xref-ref-49-1" class="xref-bibr" href="#ref-49">49</a>). Consistent with this paradigm, we found that HIV-2-specific CD57<sup>+</sup>CD4<sup>+</sup> T cells generally lacked IL-2 production and instead predominantly made IFN-γ. However, the HIV-2-specific CD57<sup>−</sup> CD4<sup>+</sup> T cells were more polyfunctional, with 29% producing IFN-γ and IL-2, and 20% producing only IL-2. We observed similar trends
                        in the two HIV-1-infected individuals who had a substantial CD57<sup>+</sup> HIV-specific CD4<sup>+</sup> T cell response (data not shown). These data demonstrate that the difference in frequency of HIV-specific CD4<sup>+</sup> T cells between asymptomatic HIV-1- and HIV-2-infected donors is predominantly driven by the non-terminally differentiated
                        subset, which more frequently express IL-2. These cells are functionally more consistent with memory than effector Th cells
                        and should retain proliferative capacity.
                     </p>
                     
                     <p id="p-28">Intriguingly, despite the increased functionality of HIV-2-specific CD4<sup>+</sup> T cells, we found that the maintenance of CD4<sup>+</sup> T cell help in HIV-2-infected individuals is not reflected in increased proliferative capacity of HIV-2-specific CD8<sup>+</sup> T cells. This is in keeping with other studies that have demonstrated similar antiviral activity, phenotype, and function
                        of virus-specific CD8<sup>+</sup> T cells in HIV-1- and HIV-2-infected donors at similar stages of disease (<a id="xref-ref-20-3" class="xref-bibr" href="#ref-20">20</a>, <a id="xref-ref-21-2" class="xref-bibr" href="#ref-21">21</a>). One potential explanation for these findings is that HIV-2-specific CD4<sup>+</sup> T cells themselves may have direct effector functions that are protective and antiviral and may be contributing to control
                        of HIV-2 viremia via this mechanism. Alternatively, other aspects of CD8<sup>+</sup> T cell functionality that require CD4<sup>+</sup> T cell help may be enhanced in HIV-2-infected individuals. Indeed, many recent studies, mostly in murine models, have investigated
                        the requirement of CD8<sup>+</sup> T cells for CD4<sup>+</sup> T cell help, and have suggested that CD4<sup>+</sup> T cells are required at the time of primary infection to ensure the expansion and maintenance of memory CD8<sup>+</sup> T cells in a secondary response (<a id="xref-ref-50-1" class="xref-bibr" href="#ref-50">50</a>). In the absence of CD4<sup>+</sup> T cell help, the secondary CD8<sup>+</sup> T cell response is both smaller (<a id="xref-ref-51-1" class="xref-bibr" href="#ref-51">51</a>) and functionally impaired (<a id="xref-ref-51-2" class="xref-bibr" href="#ref-51">51</a>, <a id="xref-ref-52-1" class="xref-bibr" href="#ref-52">52</a>): that impairment is manifested in both reduced proliferative capacity and effector potential (lytic activity and IFN-γ secretion).
                        Fewer studies have examined the role of CD4<sup>+</sup> T cell help in supporting the CD8<sup>+</sup> T cell response in persistent infection, but in the lymphocytic choriomeningitis virus model, the maintenance and function
                        of memory CD8<sup>+</sup> T cells are impaired in the absence of CD4<sup>+</sup> T cell help (<a id="xref-ref-53-1" class="xref-bibr" href="#ref-53">53</a>). Consistent with these observations, impairments in HIV-1-specific CD8<sup>+</sup> T cell phenotype and function have been noted and ascribed to the lack of appropriate CD4<sup>+</sup> T cell help (<a id="xref-ref-54-1" class="xref-bibr" href="#ref-54">54</a>, <a id="xref-ref-55-1" class="xref-bibr" href="#ref-55">55</a>, <a id="xref-ref-56-1" class="xref-bibr" href="#ref-56">56</a>). Although we only measured the proliferative capacity of HIV-2-specific CD8<sup>+</sup> T cells, we found this activity to be intact in HIV-2-infected subjects who have preserved HIV-2-specific CD4<sup>+</sup> T cell function.
                     </p>
                     
                     <p id="p-29">Other studies have failed to detect differences in the magnitude or cytokine secretion profile of HIV-specific CD8<sup>+</sup> T cells between HIV-1- and HIV-2-infected subjects (<a id="xref-ref-20-4" class="xref-bibr" href="#ref-20">20</a>, <a id="xref-ref-21-3" class="xref-bibr" href="#ref-21">21</a>, <a id="xref-ref-25-4" class="xref-bibr" href="#ref-25">25</a>). Similarly, we did not detect significant differences in the proliferative capacity of HIV-specific CD8<sup>+</sup> T cells between HIV-1- and HIV-2-infected subjects, despite the marked discrepancy in the levels of CD4<sup>+</sup> T cell help and viral load between the two groups. Assuming that CD8<sup>+</sup> T cells are the major antiviral effector arm of the immune system, it becomes difficult to reconcile our results. However,
                        it is certainly plausible that other aspects of CD8<sup>+</sup> T cell function than those we have measured are more effective in HIV-2 infection than in HIV-1 infection and are responsible
                        for the differences in control of these two human pathogens. Additionally, preserved HIV-2-specific CD4<sup>+</sup> T cell help could support other host immune responses such as enhanced neutralizing Ab activity (<a id="xref-ref-57-1" class="xref-bibr" href="#ref-57">57</a>, <a id="xref-ref-58-1" class="xref-bibr" href="#ref-58">58</a>) or improved activation of APCs.
                     </p>
                     
                     <p id="p-30">Although our cohorts of HIV-1- and HIV-2-infected individuals were matched in terms of CD4<sup>+</sup> T cell counts (both percentages and absolute counts are similar at equivalent stages of disease), plasma viral load was &gt;10-fold
                        lower among asymptomatic HIV-2-infected individuals. Either as a cause or consequence of this lower viral burden, HIV-specific
                        CD4<sup>+</sup> T cells retain a robust proliferative capacity and ability to secrete multiple cytokines. Our findings of preserved polyfunctional
                        CD4<sup>+</sup> T cell help in HIV-2 infection should provide a foundation upon which to investigate those aspects of human CD8<sup>+</sup> T cell activity that are dependent on CD4<sup>+</sup> T cell help. Our data also provide support for vaccine strategies that are designed to elicit a strong and polyfunctional
                        CD4<sup>+</sup> T cell response in addition to a CD8<sup>+</sup> T cell response to HIV.
                     </p>
                     
                  </div>
                  <div class="section" id="sec-17">
                     <div class="section-nav"><a href="#sec-16" title="Discussion" class="prev-section-link"><span>Previous Section</span></a><a href="#sec-18" title="Disclosures" class="next-section-link"><span>Next Section</span></a></div>
                     
                     <h2>Acknowledgments</h2>
                     
                     <p id="p-31">We thank the medical, nursing, field, and laboratory staff of the Genitourinary Medicine Clinic in The Gambia for all their
                        help in obtaining blood samples for this study. We thank Akum Aveika, Ramu Sarge-Njie, and Bakary Sanneh for patient recruitment
                        and laboratory assistance. We also acknowledge the generosity of the patients from the clinic who donated these blood samples.
                        Finally, we thank Joseph Casazza, Melissa Precopio, Jay Vasudevan, and David Price for critical review of the manuscript.
                     </p>
                     
                  </div>
                  <div class="section" id="sec-18">
                     <div class="section-nav"><a href="#sec-17" title="Acknowledgments" class="prev-section-link"><span>Previous Section</span></a><a href="#fn-group-1" title="Footnotes" class="next-section-link"><span>Next Section</span></a></div>
                     
                     <h2>Disclosures</h2>
                     
                     <p id="p-32">The authors have no financial conflict of interest.</p>
                     
                  </div>
                  <div class="section fn-group" id="fn-group-1">
                     <div class="section-nav"><a href="#sec-18" title="Disclosures" class="prev-section-link"><span>Previous Section</span></a><a href="#ref-list-1" title="References" class="next-section-link"><span>Next Section</span></a></div>
                     <h2>Footnotes</h2>
                     <ul>
                        <li class="fn" id="fn-1">
                           
                           <p id="p-33">The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore
                              be hereby marked <em>advertisement</em> in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
                           </p>
                           
                        </li>
                        <li class="fn" id="fn-2">
                           
                           
                           <p id="p-34"><a class="rev-xref" href="#xref-fn-2-1">↵</a><span class="fn-label">1</span> This work was supported by the Medical Research Council (U.K.).
                           </p>
                           
                        </li>
                        <li class="fn" id="fn-3">
                           
                           
                           <p id="p-35"><a class="rev-xref" href="#xref-fn-3-1">↵</a><span class="fn-label">2</span> Address correspondence and reprint requests to Prof. Sarah L. Rowland-Jones, Director of Research, MRC Laboratories, P.O.
                              Box 273, Banjul, The Gambia. E-mail address: <a href="mailto:srowland-jones@mrc.gm">srowland-jones@mrc.gm</a></p>
                           
                        </li>
                        <li class="fn" id="fn-4">
                           
                           
                           <p id="p-36"><a class="rev-xref" href="#xref-fn-4-1">↵</a><span class="fn-label">3</span> Abbreviations used in this paper: LTNP, long-term nonprogressor; ICS, intracellular cytokine staining; ART, antiretroviral
                              therapy; SEB, staphylococcal enterotoxin B.
                           </p>
                           
                        </li>
                     </ul>
                  </div>
                  <ul class="history-list">
                     <li xmlns:hwp="http://schema.highwire.org/Journal" class="received" hwp:start="2005-12-29"><span class="received-label">Received </span>December 29, 2005.
                     </li>
                     <li xmlns:hwp="http://schema.highwire.org/Journal" class="accepted" hwp:start="2006-03-10"><span class="accepted-label">Accepted </span>March 10, 2006.
                     </li>
                  </ul>
                  <ul class="copyright-statement">
                     <li class="fn" id="copyright-statement-1">Copyright © 2006 by The American Association of Immunologists</li>
                  </ul>
                  <div class="section ref-list" id="ref-list-1">
                     <div class="section-nav"><a href="#fn-group-1" title="Footnotes" class="prev-section-link"><span>Previous Section</span></a><div class="nav-placeholder">&nbsp;</div>
                     </div>
                     <h2>References</h2>
                     <ol class="cit-list">
                        <li><a class="rev-xref-ref" href="#xref-ref-1-1" title="View reference 1 in text" id="ref-1">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.1">
                              <div class="cit-metadata"><cite> Rosenberg, E. S.,  J. M. Billingsley,  A. M. Caliendo,  S. L. Boswell,  P. E. Sax,  S. A. Kalams,  B. D. Walker.  <span class="cit-pub-date">1997</span>. Vigorous HIV-1-specific CD4<sup>+</sup> T cell responses associated with control of viremia. <span class="cit-source">Science</span> <span class="cit-vol">278</span>: <span class="cit-fpage">1447</span>-1450. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/cgi/ijlink?linkType=ABST&amp;journalCode=sci&amp;resid=278/5342/1447" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-2-1" title="View reference 2 in text" id="ref-2">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.2">
                              <div class="cit-metadata"><cite> Rosenberg, E. S.,  M. Altfeld,  S. H. Poon,  M. N. Phillips,  B. M. Wilkes,  R. L. Eldridge,  G. K. Robbins,  R. T. D’Aquila,
                                    P. J. Goulder,  B. D. Walker.  <span class="cit-pub-date">2000</span>. Immune control of HIV-1 after early treatment of acute infection. <span class="cit-source">Nature</span> <span class="cit-vol">407</span>: <span class="cit-fpage">523</span>-526. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/external-ref?access_num=10.1038/35035103&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jimmunol.org/external-ref?access_num=11029005&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-3-1" title="View reference 3 in text" id="ref-3">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.3">
                              <div class="cit-metadata"><cite> Clerici, M.,  N. I. Stocks,  R. A. Zajac,  R. N. Boswell,  D. R. Lucey,  C. S. Via,  G. M. Shearer.  <span class="cit-pub-date">1989</span>. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive
                                    patients: independence of CD4<sup>+</sup> cell numbers and clinical staging. <span class="cit-source">J. Clin. Invest.</span> <span class="cit-vol">84</span>: <span class="cit-fpage">1892</span>-1899. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/external-ref?access_num=2574188&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-4-1" title="View reference 4 in text" id="ref-4">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.4">
                              <div class="cit-metadata"><cite> Poulsen, A. G.,  P. Aaby,  O. Larsen,  H. Jensen,  A. Naucler,  I. M. Lisse,  C. B. Christiansen,  F. Dias,  M. Melbye. 
                                    <span class="cit-pub-date">1997</span>. 9-Year HIV-2-associated mortality in an urban community in Bissau, West Africa. <span class="cit-source">Lancet</span> <span class="cit-vol">349</span>: <span class="cit-fpage">911</span>-914. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/external-ref?access_num=10.1016/S0140-6736(96)04402-9&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jimmunol.org/external-ref?access_num=9093252&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-5-1" title="View reference 5 in text" id="ref-5">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.5">
                              <div class="cit-metadata"><cite> Schim van der Loeff, M. F.,  S. Jaffar,  A. A. Aveika,  S. Sabally,  T. Corrah,  E. Harding,  A. Alabi,  A. Bayang,  K. Ariyoshi,
                                    H. C. Whittle.  <span class="cit-pub-date">2002</span>. Mortality of HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients in a clinic-based cohort in The Gambia. <span class="cit-source">AIDS</span> <span class="cit-vol">16</span>: <span class="cit-fpage">1775</span>-1783. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/external-ref?access_num=10.1097/00002030-200209060-00010&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jimmunol.org/external-ref?access_num=12218389&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-6-1" title="View reference 6 in text" id="ref-6">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.6">
                              <div class="cit-metadata"><cite> Ariyoshi, K.,  S. Jaffar,  A. S. Alabi,  N. Berry,  M. Schim van der Loeff,  S. Sabally,  P. T. N′Gom,  T. Corrah,  R. Tedder,
                                    H. Whittle.  <span class="cit-pub-date">2000</span>. Plasma RNA viral load predicts the rate of CD4 T cell decline and death in HIV-2-infected patients in West Africa. <span class="cit-source">AIDS</span> <span class="cit-vol">14</span>: <span class="cit-fpage">339</span>-344. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/external-ref?access_num=10.1097/00002030-200003100-00006&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jimmunol.org/external-ref?access_num=10770535&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-7-1" title="View reference 7 in text" id="ref-7">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.7">
                              <div class="cit-metadata"><cite> Arien, K. K.,  A. Abraha,  M. E. Quinones-Mateu,  L. Kestens,  G. Vanham,  E. J. Arts.  <span class="cit-pub-date">2005</span>. The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates.
                                    <span class="cit-source">J. Virol.</span> <span class="cit-vol">79</span>: <span class="cit-fpage">8979</span>-8990. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=79/14/8979" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-8-1" title="View reference 8 in text" id="ref-8">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.8">
                              <div class="cit-metadata"><cite> Blaak, H.,  P. H. Boers,  M. Schutten,  M. E. Van Der Enden,  A. D. Osterhaus.  <span class="cit-pub-date">2004</span>. HIV-2-infected individuals with undetectable plasma viremia carry replication-competent virus in peripheral blood lymphocytes.
                                    <span class="cit-source">J. Acquir. Immune. Defic. Syndr.</span> <span class="cit-vol">36</span>: <span class="cit-fpage">777</span>-782. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/external-ref?access_num=10.1097/00126334-200407010-00003&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jimmunol.org/external-ref?access_num=15213560&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-9-1" title="View reference 9 in text" id="ref-9">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.9">
                              <div class="cit-metadata"><cite> McClure, M. O.,  Q. J. Sattentau,  P. C. Beverley,  J. P. Hearn,  A. K. Fitzgerald,  A. J. Zuckerman,  R. A. Weiss.  <span class="cit-pub-date">1987</span>. HIV infection of primate lymphocytes and conservation of the CD4 receptor. <span class="cit-source">Nature</span> <span class="cit-vol">330</span>: <span class="cit-fpage">487</span>-489. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/external-ref?access_num=10.1038/330487a0&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jimmunol.org/external-ref?access_num=2446142&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-10-1" title="View reference 10 in text" id="ref-10">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.10">
                              <div class="cit-metadata"><cite> Schramm, B.,  M. L. Penn,  E. H. Palacios,  R. M. Grant,  F. Kirchhoff,  M. A. Goldsmith.  <span class="cit-pub-date">2000</span>. Cytopathicity of human immunodeficiency virus type 2 (HIV-2) in human lymphoid tissue is coreceptor dependent and comparable
                                    to that of HIV-1. <span class="cit-source">J. Virol.</span> <span class="cit-vol">74</span>: <span class="cit-fpage">9594</span>-9600. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=74/20/9594" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-11-1" title="View reference 11 in text" id="ref-11">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.11">
                              <div class="cit-metadata"><cite> Ariyoshi, K.,  N. Berry,  A. Wilkins,  D. Ricard,  P. Aaby,  A. Naucler,  P. T. Ngom,  O. Jobe,  S. Jaffar,  F. Dias, et
                                    al<strong></strong> <span class="cit-pub-date">1996</span>. A community-based study of human immunodeficiency virus type 2 provirus load in rural village in West Africa. <span class="cit-source">J. Infect. Dis.</span> <span class="cit-vol">173</span>: <span class="cit-fpage">245</span>-248. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/cgi/ijlink?linkType=ABST&amp;journalCode=jinfdis&amp;resid=173/1/245" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-12-1" title="View reference 12 in text" id="ref-12">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.12">
                              <div class="cit-metadata"><cite> Berry, N.,  K. Ariyoshi,  O. Jobe,  P. T. Ngum,  T. Corrah,  A. Wilkins,  H. Whittle,  R. Tedder.  <span class="cit-pub-date">1994</span>. HIV type 2 proviral load measured by quantitative polymerase chain reaction correlates with CD4<sup>+</sup> lymphopenia in HIV type 2-infected individuals. <span class="cit-source">AIDS Res. Hum. Retroviruses</span> <span class="cit-vol">10</span>: <span class="cit-fpage">1031</span>-1037. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/external-ref?access_num=7811534&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-13-1" title="View reference 13 in text" id="ref-13">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.13">
                              <div class="cit-metadata"><cite> Sarr, A. D.,  S. Popper,  I. Thior,  D. J. Hamel,  J. L. Sankale,  T. Siby,  R. Marlink,  M. Essex,  S. Mboup,  P. Kanki.
                                    <span class="cit-pub-date">1999</span>. Relation between HIV-2 proviral load and CD4<sup>+</sup> lymphocyte count differs in monotypic and dual HIV infections. <span class="cit-source">J. Hum. Virol.</span> <span class="cit-vol">2</span>: <span class="cit-fpage">45</span>-51. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/external-ref?access_num=10200599&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-14-1" title="View reference 14 in text" id="ref-14">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.14">
                              <div class="cit-metadata"><cite> Berry, N.,  S. Jaffar,  M. Schim van der Loeff,  K. Ariyoshi,  E. Harding,  P. T. N′Gom,  F. Dias,  A. Wilkins,  D. Ricard,
                                    P. Aaby, et al<strong></strong> <span class="cit-pub-date">2002</span>. Low level viremia and high CD4% predict normal survival in a cohort of HIV type-2-infected villagers. <span class="cit-source">AIDS Res. Hum. Retroviruses</span> <span class="cit-vol">18</span>: <span class="cit-fpage">1167</span>-1173. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/external-ref?access_num=10.1089/08892220260387904&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jimmunol.org/external-ref?access_num=12487822&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-15-1" title="View reference 15 in text" id="ref-15">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.15">
                              <div class="cit-metadata"><cite> Kanki, P. J.,  K. U. Travers,  S. MBoup,  C. C. Hsieh,  R. G. Marlink,  A. Gueye-NDiaye,  T. Siby,  I. Thior,  M. Hernandez-Avila,
                                    J. L. Sankale, et al<strong></strong> <span class="cit-pub-date">1994</span>. Slower heterosexual spread of HIV-2 than HIV-1. <span class="cit-source">Lancet</span> <span class="cit-vol">343</span>: <span class="cit-fpage">943</span>-946. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/external-ref?access_num=10.1016/S0140-6736(94)90065-5&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jimmunol.org/external-ref?access_num=7909009&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-16-1" title="View reference 16 in text" id="ref-16">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.16">
                              <div class="cit-metadata"><cite> O’Donovan, D.,  K. Ariyoshi,  P. Milligan,  M. Ota,  L. Yamuah,  R. Sarge-Njie,  H. Whittle.  <span class="cit-pub-date">2000</span>. Maternal plasma viral RNA levels determine marked differences in mother-to-child transmission rates of HIV-1 and HIV-2 in
                                    The Gambia: MRC/Gambia Government/University College London Medical School working group on mother-child transmission of HIV.
                                    <span class="cit-source">AIDS</span> <span class="cit-vol">14</span>: <span class="cit-fpage">441</span>-448. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/external-ref?access_num=10.1097/00002030-200003100-00019&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jimmunol.org/external-ref?access_num=10770548&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-17-1" title="View reference 17 in text" id="ref-17">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.17">
                              <div class="cit-metadata"><cite> Whittle, H. C.,  K. Ariyoshi,  S. Rowland-Jones.  <span class="cit-pub-date">1998</span>. HIV-2 and T cell recognition. <span class="cit-source">Curr. Opin. Immunol.</span> <span class="cit-vol">10</span>: <span class="cit-fpage">382</span>-387. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/external-ref?access_num=10.1016/S0952-7915(98)80108-8&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jimmunol.org/external-ref?access_num=9722912&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-18-1" title="View reference 18 in text" id="ref-18">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.18">
                              <div class="cit-metadata"><cite> Gotch, F.,  S. N. McAdam,  C. E. Allsopp,  A. Gallimore,  J. Elvin,  M. P. Kieny,  A. V. Hill,  A. J. McMichael,  H. C. Whittle.
                                    <span class="cit-pub-date">1993</span>. Cytotoxic T cells in HIV2 seropositive Gambians: identification of a virus-specific MHC-restricted peptide epitope. <span class="cit-source">J. Immunol.</span> <span class="cit-vol">151</span>: <span class="cit-fpage">3361</span>-3369. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/cgi/ijlink?linkType=ABST&amp;journalCode=jimmunol&amp;resid=151/6/3361" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span></a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-19-1" title="View reference 19 in text" id="ref-19">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.19">
                              <div class="cit-metadata"><cite> Bertoletti, A.,  F. Cham,  S. McAdam,  T. Rostron,  S. Rowland-Jones,  S. Sabally,  T. Corrah,  K. Ariyoshi,  H. Whittle.
                                    <span class="cit-pub-date">1998</span>. Cytotoxic T cells from human immunodeficiency virus type 2-infected patients frequently cross-react with different human
                                    immunodeficiency virus type 1 clades. <span class="cit-source">J. Virol.</span> <span class="cit-vol">72</span>: <span class="cit-fpage">2439</span>-2448. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=72/3/2439" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-20-1" title="View reference 20 in text" id="ref-20">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.20">
                              <div class="cit-metadata"><cite> Jaye, A.,  R. Sarge-Njie,  M. Schim van der Loeff,  J. Todd,  A. Alabi,  S. Sabally,  T. Corrah,  H. Whittle.  <span class="cit-pub-date">2004</span>. No differences in cellular immune responses between asymptomatic HIV type 1- and type 2-infected Gambian patients. <span class="cit-source">J. Infect. Dis.</span> <span class="cit-vol">189</span>: <span class="cit-fpage">498</span>-505. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/cgi/ijlink?linkType=ABST&amp;journalCode=jinfdis&amp;resid=189/3/498" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-21-1" title="View reference 21 in text" id="ref-21">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.21">
                              <div class="cit-metadata"><cite> Gillespie, G. M.,  S. Pinheiro,  M. Sayeid-Al-Jamee,  A. Alabi,  S. Kaye,  S. Sabally,  R. Sarge-Njie,  H. Njai,  K. Joof,
                                    A. Jaye, et al<strong></strong> <span class="cit-pub-date">2005</span>. CD8<sup>+</sup> T cell responses to human immunodeficiency viruses type 2 (HIV-2) and type 1 (HIV-1) gag proteins are distinguishable by
                                    magnitude and breadth but not cellular phenotype. <span class="cit-source">Eur. J. Immunol.</span> <span class="cit-vol">35</span>: <span class="cit-fpage">1445</span>-1453. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/external-ref?access_num=10.1002/eji.200526007&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jimmunol.org/external-ref?access_num=15832290&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-22-1" title="View reference 22 in text" id="ref-22">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.22">
                              <div class="cit-metadata"><cite> Sousa, A. E.,  A. F. Chaves,  A. Loureiro,  R. M. Victorino.  <span class="cit-pub-date">2001</span>. Comparison of the frequency of interleukin (IL)-2-, interferon-γ-, and IL-4-producing T cells in 2 diseases, human immunodeficiency
                                    virus types 1 and 2, with distinct clinical outcomes. <span class="cit-source">J. Infect. Dis.</span> <span class="cit-vol">184</span>: <span class="cit-fpage">552</span>-559. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/cgi/ijlink?linkType=ABST&amp;journalCode=jinfdis&amp;resid=184/5/552" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-23-1" title="View reference 23 in text" id="ref-23">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.23">
                              <div class="cit-metadata"><cite> Pinto, L. A.,  M. J. Covas,  R. M. Victorino.  <span class="cit-pub-date">1993</span>. T-helper cross reactivity to viral recombinant proteins in HIV-2-infected patients. <span class="cit-source">AIDS</span> <span class="cit-vol">7</span>: <span class="cit-fpage">1389</span>-1391. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/external-ref?access_num=8267915&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-24-1" title="View reference 24 in text" id="ref-24">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.24">
                              <div class="cit-metadata"><cite> Pinto, L. A.,  M. J. Covas,  R. M. Victorino.  <span class="cit-pub-date">1995</span>. T-helper reactivity to simian immunodeficiency virus gag synthetic peptides in human immunodeficiency virus type 2 infected
                                    individuals. <span class="cit-source">J. Med. Virol.</span> <span class="cit-vol">47</span>: <span class="cit-fpage">139</span>-144. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/external-ref?access_num=8830117&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-25-1" title="View reference 25 in text" id="ref-25">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.25">
                              <div class="cit-metadata"><cite> Zheng, N. N.,  N. B. Kiviat,  P. S. Sow,  S. E. Hawes,  A. Wilson,  H. Diallo-Agne,  C. W. Critchlow,  G. S. Gottlieb,  L.
                                    Musey,  M. J. McElrath.  <span class="cit-pub-date">2004</span>. Comparison of human immunodeficiency virus (HIV)-specific T-cell responses in HIV-1- and HIV-2-infected individuals in Senegal.
                                    <span class="cit-source">J. Virol.</span> <span class="cit-vol">78</span>: <span class="cit-fpage">13934</span>-13942. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=78/24/13934" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-26-1" title="View reference 26 in text" id="ref-26">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.26">
                              <div class="cit-metadata"><cite> Hansmann, A.,  M. F. Schim van der Loeff,  S. Kaye,  A. A. Awasana,  R. Sarge-Njie,  D. O’Donovan,  K. Ariyoshi,  A. Alabi,
                                    P. Milligan,  H. C. Whittle.  <span class="cit-pub-date">2005</span>. Baseline plasma viral load and CD4 cell percentage predict survival in HIV-1- and HIV-2-infected women in a community-based
                                    cohort in The Gambia. <span class="cit-source">J. Acquir. Immune Defic. Syndr.</span> <span class="cit-vol">38</span>: <span class="cit-fpage">335</span>-341. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/external-ref?access_num=15735454&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-27-1" title="View reference 27 in text" id="ref-27">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.27">
                              <div class="cit-metadata"><cite> Alabi, A. S.,  S. Jaffar,  K. Ariyoshi,  T. Blanchard,  M. Schim van der Loeff,  A. A. Awasana,  T. Corrah,  S. Sabally,
                                    R. Sarge-Njie,  F. Cham-Jallow, et al<strong></strong> <span class="cit-pub-date">2003</span>. Plasma viral load, CD4 cell percentage, HLA and survival of HIV-1, HIV-2, and dually infected Gambian patients. <span class="cit-source">AIDS</span> <span class="cit-vol">17</span>: <span class="cit-fpage">1513</span>-1520. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/external-ref?access_num=10.1097/00002030-200307040-00012&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jimmunol.org/external-ref?access_num=12824789&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-28-1" title="View reference 28 in text" id="ref-28">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.28">
                              <div class="cit-metadata"><cite> Berry, N.,  K. Ariyoshi,  S. Jaffar,  S. Sabally,  T. Corrah,  R. Tedder,  H. Whittle.  <span class="cit-pub-date">1998</span>. Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection.
                                    <span class="cit-source">J. Hum. Virol.</span> <span class="cit-vol">1</span>: <span class="cit-fpage">457</span>-468. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/external-ref?access_num=10195267&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-29-1" title="View reference 29 in text" id="ref-29">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.29">
                              <div class="cit-metadata"><cite> Ariyoshi, K.,  M. Schim van der Loeff,  N. Berry,  S. Jaffar,  H. Whittle.  <span class="cit-pub-date">1999</span>. Plasma HIV viral load in relation to season and to <em>Plasmodium falciparum</em> parasitaemia. <span class="cit-source">AIDS</span> <span class="cit-vol">13</span>: <span class="cit-fpage">1145</span>-1146. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/external-ref?access_num=10.1097/00002030-199906180-00023&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jimmunol.org/external-ref?access_num=10397550&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-30-1" title="View reference 30 in text" id="ref-30">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.30">
                              <div class="cit-metadata"><cite> Cham, F.,  L. Heyndrickx,  W. Janssens,  G. Van der Auwera,  K. Vereecken,  K. De Houwer,  S. Coppens,  H. Whittle,  G. van
                                    der Groen.  <span class="cit-pub-date">2000</span>. Study of HIV type 1 gag/env variability in The Gambia, using a multiplex DNA polymerase chain reaction. <span class="cit-source">AIDS Res. Hum. Retroviruses</span> <span class="cit-vol">16</span>: <span class="cit-fpage">1915</span>-1919. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/external-ref?access_num=10.1089/08892220050195874&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jimmunol.org/external-ref?access_num=11118077&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-31-1" title="View reference 31 in text" id="ref-31">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.31">
                              <div class="cit-metadata"><cite> Andersson, S.,  H. Norrgren,  F. Dias,  G. Biberfeld,  J. Albert.  <span class="cit-pub-date">1999</span>. Molecular characterization of human immunodeficiency virus (HIV)-1 and -2 in individuals from Guinea-bissau with single
                                    or dual infections: predominance of a distinct HIV-1 subtype A/G recombinant in West Africa. <span class="cit-source">Virology</span> <span class="cit-vol">262</span>: <span class="cit-fpage">312</span>-320. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/external-ref?access_num=10.1006/viro.1999.9867&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jimmunol.org/external-ref?access_num=10502510&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-32-1" title="View reference 32 in text" id="ref-32">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.32">
                              <div class="cit-metadata"><cite> Berry, N.,  K. Ariyoshi,  P. Balfe,  R. Tedder,  H. Whittle.  <span class="cit-pub-date">2001</span>. Sequence specificity of the human immunodeficiency virus type 2 (HIV-2) long terminal repeat u3 region in vivo allows subtyping
                                    of the principal HIV-2 viral subtypes a and b. <span class="cit-source">AIDS Res. Hum. Retroviruses</span> <span class="cit-vol">17</span>: <span class="cit-fpage">263</span>-267. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/external-ref?access_num=10.1089/088922201750063197&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jimmunol.org/external-ref?access_num=11177410&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-33-1" title="View reference 33 in text" id="ref-33">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.33">
                              <div class="cit-metadata"><cite> Pitcher, C. J.,  C. Quittner,  D. M. Peterson,  M. Connors,  R. A. Koup,  V. C. Maino,  L. J. Picker.  <span class="cit-pub-date">1999</span>. HIV-1-specific CD4<sup>+</sup> T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. <span class="cit-source">Nat. Med.</span> <span class="cit-vol">5</span>: <span class="cit-fpage">518</span>-525. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/external-ref?access_num=10.1038/8400&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jimmunol.org/external-ref?access_num=10229228&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-34-1" title="View reference 34 in text" id="ref-34">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.34">
                              <div class="cit-metadata"><cite> Betts, M. R.,  D. R. Ambrozak,  D. C. Douek,  S. Bonhoeffer,  J. M. Brenchley,  J. P. Casazza,  R. A. Koup,  L. J. Picker.
                                    <span class="cit-pub-date">2001</span>. Analysis of total human immunodeficiency virus (HIV)-specific CD4<sup>+</sup> and CD8<sup>+</sup> T-cell responses: relationship to viral load in untreated HIV infection. <span class="cit-source">J. Virol.</span> <span class="cit-vol">75</span>: <span class="cit-fpage">11983</span>-11991. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=75/24/11983" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-35-1" title="View reference 35 in text" id="ref-35">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.35">
                              <div class="cit-metadata"><cite> Addo, M. M.,  X. G. Yu,  A. Rathod,  D. Cohen,  R. L. Eldridge,  D. Strick,  M. N. Johnston,  C. Corcoran,  A. G. Wurcel,
                                    C. A. Fitzpatrick, et al<strong></strong> <span class="cit-pub-date">2003</span>. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against
                                    the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. <span class="cit-source">J. Virol.</span> <span class="cit-vol">77</span>: <span class="cit-fpage">2081</span>-2092. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=77/3/2081" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-36-1" title="View reference 36 in text" id="ref-36">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.36">
                              <div class="cit-metadata"><cite> Guyader, M.,  M. Emerman,  P. Sonigo,  F. Clavel,  L. Montagnier,  M. Alizon.  <span class="cit-pub-date">1987</span>. Genome organization and transactivation of the human immunodeficiency virus type 2. <span class="cit-source">Nature</span> <span class="cit-vol">326</span>: <span class="cit-fpage">662</span>-669. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/external-ref?access_num=10.1038/326662a0&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jimmunol.org/external-ref?access_num=3031510&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-37-1" title="View reference 37 in text" id="ref-37">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.37">
                              <div class="cit-metadata"><cite> Brenchley, J. M.,  N. J. Karandikar,  M. R. Betts,  D. R. Ambrozak,  B. J. Hill,  L. E. Crotty,  J. P. Casazza,  J. Kuruppu,
                                    S. A. Migueles,  M. Connors, et al<strong></strong> <span class="cit-pub-date">2003</span>. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8<sup>+</sup> T cells. <span class="cit-source">Blood</span> <span class="cit-vol">101</span>: <span class="cit-fpage">2711</span>-2720. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/cgi/ijlink?linkType=ABST&amp;journalCode=bloodjournal&amp;resid=101/7/2711" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-38-1" title="View reference 38 in text" id="ref-38">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.38">
                              <div class="cit-metadata"><cite> Iyasere, C.,  J. C. Tilton,  A. J. Johnson,  S. Younes,  B. Yassine-Diab,  R. P. Sekaly,  W. W. Kwok,  S. A. Migueles,  A.
                                    C. Laborico,  W. L. Shupert, et al<strong></strong> <span class="cit-pub-date">2003</span>. Diminished proliferation of human immunodeficiency virus-specific CD4<sup>+</sup> T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2. <span class="cit-source">J. Virol.</span> <span class="cit-vol">77</span>: <span class="cit-fpage">10900</span>-10909. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=77/20/10900" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-39-1" title="View reference 39 in text" id="ref-39">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.39">
                              <div class="cit-metadata"><cite> Younes, S. A.,  B. Yassine-Diab,  A. R. Dumont,  M. R. Boulassel,  Z. Grossman,  J. P. Routy,  R. P. Sekaly.  <span class="cit-pub-date">2003</span>. HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4<sup>+</sup> T cells endowed with proliferative capacity. <span class="cit-source">J. Exp. Med.</span> <span class="cit-vol">198</span>: <span class="cit-fpage">1909</span>-1922. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/cgi/ijlink?linkType=ABST&amp;journalCode=jem&amp;resid=198/12/1909" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-40-1" title="View reference 40 in text" id="ref-40">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.40">
                              <div class="cit-metadata"><cite> Musey, L. K.,  J. N. Krieger,  J. P. Hughes,  T. W. Schacker,  L. Corey,  M. J. McElrath.  <span class="cit-pub-date">1999</span>. Early and persistent human immunodeficiency virus type 1 (HIV-1)-specific T helper dysfunction in blood and lymph nodes
                                    following acute HIV-1 infection. <span class="cit-source">J. Infect. Dis.</span> <span class="cit-vol">180</span>: <span class="cit-fpage">278</span>-284. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/cgi/ijlink?linkType=ABST&amp;journalCode=jinfdis&amp;resid=180/2/278" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-41-1" title="View reference 41 in text" id="ref-41">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.41">
                              <div class="cit-metadata"><cite> Douek, D. C.,  J. M. Brenchley,  M. R. Betts,  D. R. Ambrozak,  B. J. Hill,  Y. Okamoto,  J. P. Casazza,  J. Kuruppu,  K.
                                    Kunstman,  S. Wolinsky, et al<strong></strong> <span class="cit-pub-date">2002</span>. HIV preferentially infects HIV-specific CD4<sup>+</sup> T cells. <span class="cit-source">Nature</span> <span class="cit-vol">417</span>: <span class="cit-fpage">95</span>-98. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/external-ref?access_num=10.1038/417095a&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jimmunol.org/external-ref?access_num=11986671&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-42-1" title="View reference 42 in text" id="ref-42">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.42">
                              <div class="cit-metadata"><cite> Li, Q.,  L. Duan,  J. D. Estes,  Z. M. Ma,  T. Rourke,  Y. Wang,  C. Reilly,  J. Carlis,  C. J. Miller,  A. T. Haase.  <span class="cit-pub-date">2005</span>. Peak SIV replication in resting memory CD4<sup>+</sup> T cells depletes gut lamina propria CD4<sup>+</sup> T cells. <span class="cit-source">Nature</span> <span class="cit-vol">434</span>: <span class="cit-fpage">1148</span>-1152. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/external-ref?access_num=15793562&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-43-1" title="View reference 43 in text" id="ref-43">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.43">
                              <div class="cit-metadata"><cite> Mattapallil, J. J.,  D. C. Douek,  B. Hill,  Y. Nishimura,  M. Martin,  M. Roederer.  <span class="cit-pub-date">2005</span>. Massive infection and loss of memory CD4<sup>+</sup> T cells in multiple tissues during acute SIV infection. <span class="cit-source">Nature</span> <span class="cit-vol">434</span>: <span class="cit-fpage">1093</span>-1097. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/external-ref?access_num=10.1038/nature03501&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jimmunol.org/external-ref?access_num=15793563&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-44-1" title="View reference 44 in text" id="ref-44">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.44">
                              <div class="cit-metadata"><cite> Brenchley, J. M.,  T. W. Schacker,  L. E. Ruff,  D. A. Price,  J. H. Taylor,  G. J. Beilman,  P. L. Nguyen,  A. Khoruts,
                                    M. Larson,  A. T. Haase,  D. C. Douek.  <span class="cit-pub-date">2004</span>. CD4<sup>+</sup> T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. <span class="cit-source">J. Exp. Med.</span> <span class="cit-vol">200</span>: <span class="cit-fpage">749</span>-759. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/cgi/ijlink?linkType=ABST&amp;journalCode=jem&amp;resid=200/6/749" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-45-1" title="View reference 45 in text" id="ref-45">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.45">
                              <div class="cit-metadata"><cite> Mehandru, S.,  M. A. Poles,  K. Tenner-Racz,  A. Horowitz,  A. Hurley,  C. Hogan,  D. Boden,  P. Racz,  M. Markowitz.  <span class="cit-pub-date">2004</span>. Primary HIV-1 infection is associated with preferential depletion of CD4<sup>+</sup> T lymphocytes from effector sites in the gastrointestinal tract. <span class="cit-source">J. Exp. Med.</span> <span class="cit-vol">200</span>: <span class="cit-fpage">761</span>-770. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/cgi/ijlink?linkType=ABST&amp;journalCode=jem&amp;resid=200/6/761" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-46-1" title="View reference 46 in text" id="ref-46">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.46">
                              <div class="cit-metadata"><cite> Harari, A.,  F. Vallelian,  P. R. Meylan,  G. Pantaleo.  <span class="cit-pub-date">2005</span>. Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence. <span class="cit-source">J. Immunol.</span> <span class="cit-vol">174</span>: <span class="cit-fpage">1037</span>-1045. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/cgi/ijlink?linkType=ABST&amp;journalCode=jimmunol&amp;resid=174/2/1037" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-47-1" title="View reference 47 in text" id="ref-47">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.47">
                              <div class="cit-metadata"><cite> Harari, A.,  S. Petitpierre,  F. Vallelian,  G. Pantaleo.  <span class="cit-pub-date">2004</span>. Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with
                                    progressive disease: changes after antiretroviral therapy. <span class="cit-source">Blood</span> <span class="cit-vol">103</span>: <span class="cit-fpage">966</span>-972. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/cgi/ijlink?linkType=ABST&amp;journalCode=bloodjournal&amp;resid=103/3/966" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-48-1" title="View reference 48 in text" id="ref-48">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.48">
                              <div class="cit-metadata"><cite> Roederer, M.,  J. M. Brenchley,  M. R. Betts,  S. C. De Rosa.  <span class="cit-pub-date">2004</span>. Flow cytometric analysis of vaccine responses: how many colors are enough?. <span class="cit-source">Clin. Immunol.</span> <span class="cit-vol">110</span>: <span class="cit-fpage">199</span>-205. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/external-ref?access_num=10.1016/j.clim.2003.11.015&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jimmunol.org/external-ref?access_num=15047198&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-49-1" title="View reference 49 in text" id="ref-49">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.49">
                              <div class="cit-metadata"><cite> Wu, C. Y.,  J. R. Kirman,  M. J. Rotte,  D. F. Davey,  S. P. Perfetto,  E. G. Rhee,  B. L. Freidag,  B. J. Hill,  D. C. Douek,
                                    R. A. Seder.  <span class="cit-pub-date">2002</span>. Distinct lineages of Th1 cells have differential capacities for memory cell generation in vivo. <span class="cit-source">Nat. Immunol.</span> <span class="cit-vol">3</span>: <span class="cit-fpage">852</span>-858. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/external-ref?access_num=10.1038/ni832&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jimmunol.org/external-ref?access_num=12172546&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-50-1" title="View reference 50 in text" id="ref-50">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.50">
                              <div class="cit-metadata"><cite> Janssen, E. M.,  E. E. Lemmens,  T. Wolfe,  U. Christen,  M. G. von Herrath,  S. P. Schoenberger.  <span class="cit-pub-date">2003</span>. CD4<sup>+</sup> T cells are required for secondary expansion and memory in CD8<sup>+</sup> T lymphocytes. <span class="cit-source">Nature</span> <span class="cit-vol">421</span>: <span class="cit-fpage">852</span>-856. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/external-ref?access_num=10.1038/nature01441&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jimmunol.org/external-ref?access_num=12594515&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-51-1" title="View reference 51 in text" id="ref-51">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.51">
                              <div class="cit-metadata"><cite> Sun, J. C.,  M. J. Bevan.  <span class="cit-pub-date">2003</span>. Defective CD8 T cell memory following acute infection without CD4 T cell help. <span class="cit-source">Science</span> <span class="cit-vol">300</span>: <span class="cit-fpage">339</span>-342. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/cgi/ijlink?linkType=ABST&amp;journalCode=sci&amp;resid=300/5617/339" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-52-1" title="View reference 52 in text" id="ref-52">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.52">
                              <div class="cit-metadata"><cite> Shedlock, D. J.,  H. Shen.  <span class="cit-pub-date">2003</span>. Requirement for CD4 T cell help in generating functional CD8 T cell memory. <span class="cit-source">Science</span> <span class="cit-vol">300</span>: <span class="cit-fpage">337</span>-339. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/cgi/ijlink?linkType=ABST&amp;journalCode=sci&amp;resid=300/5617/337" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-53-1" title="View reference 53 in text" id="ref-53">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.53">
                              <div class="cit-metadata"><cite> Sun, J. C.,  M. A. Williams,  M. J. Bevan.  <span class="cit-pub-date">2004</span>. CD4<sup>+</sup> T cells are required for the maintenance, not programming, of memory CD8<sup>+</sup> T cells after acute infection. <span class="cit-source">Nat. Immunol.</span> <span class="cit-vol">5</span>: <span class="cit-fpage">927</span>-933. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/external-ref?access_num=10.1038/ni1105&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jimmunol.org/external-ref?access_num=15300249&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-54-1" title="View reference 54 in text" id="ref-54">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.54">
                              <div class="cit-metadata"><cite> Appay, V.,  P. R. Dunbar,  M. Callan,  P. Klenerman,  G. M. Gillespie,  L. Papagno,  G. S. Ogg,  A. King,  F. Lechner,  C.
                                    A. Spina, et al<strong></strong> <span class="cit-pub-date">2002</span>. Memory CD8<sup>+</sup> T cells vary in differentiation phenotype in different persistent virus infections. <span class="cit-source">Nat. Med.</span> <span class="cit-vol">8</span>: <span class="cit-fpage">379</span>-385. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/external-ref?access_num=10.1038/nm0402-379&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jimmunol.org/external-ref?access_num=11927944&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-55-1" title="View reference 55 in text" id="ref-55">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.55">
                              <div class="cit-metadata"><cite> Papagno, L.,  C. A. Spina,  A. Marchant,  M. Salio,  N. Rufer,  S. Little,  T. Dong,  G. Chesney,  A. Waters,  P. Easterbrook,
                                    et al<strong></strong> <span class="cit-pub-date">2004</span>. Immune activation and CD8<sup>+</sup> T-cell differentiation towards senescence in HIV-1 infection. <span class="cit-source">PLoS Biol.</span> <span class="cit-vol">2</span>: <span class="cit-fpage">E20</span></cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/external-ref?access_num=10.1371/journal.pbio.0020020&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jimmunol.org/external-ref?access_num=14966528&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-56-1" title="View reference 56 in text" id="ref-56">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.56">
                              <div class="cit-metadata"><cite> Lichterfeld, M.,  D. E. Kaufmann,  X. G. Yu,  S. K. Mui,  M. M. Addo,  M. N. Johnston,  D. Cohen,  G. K. Robbins,  E. Pae,
                                    G. Alter, et al<strong></strong> <span class="cit-pub-date">2004</span>. Loss of HIV-1-specific CD8<sup>+</sup> T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4<sup>+</sup> T cells. <span class="cit-source">J. Exp. Med.</span> <span class="cit-vol">200</span>: <span class="cit-fpage">701</span>-712. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/cgi/ijlink?linkType=ABST&amp;journalCode=jem&amp;resid=200/6/701" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-57-1" title="View reference 57 in text" id="ref-57">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.57">
                              <div class="cit-metadata"><cite> Bjorling, E.,  G. Scarlatti,  A. von Gegerfelt,  J. Albert,  G. Biberfeld,  F. Chiodi,  E. Norrby,  E. M. Fenyo.  <span class="cit-pub-date">1993</span>. Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection. <span class="cit-source">Virology</span> <span class="cit-vol">193</span>: <span class="cit-fpage">528</span>-530. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/external-ref?access_num=10.1006/viro.1993.1160&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jimmunol.org/external-ref?access_num=8438591&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                           </div>
                           
                        </li>
                        <li><a class="rev-xref-ref" href="#xref-ref-58-1" title="View reference 58 in text" id="ref-58">↵</a>
                           
                           
                           <div class="cit ref-cit ref-other" id="cit-176.11.6973.58">
                              <div class="cit-metadata"><cite> Robert-Guroff, M.,  K. Aldrich,  R. Muldoon,  T. L. Stern,  G. P. Bansal,  T. J. Matthews,  P. D. Markham,  R. C. Gallo,
                                    G. Franchini.  <span class="cit-pub-date">1992</span>. Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolates. <span class="cit-source">J. Virol.</span> <span class="cit-vol">66</span>: <span class="cit-fpage">3602</span>-3608.  <em>Vol. 176 No. 11</em>. </cite></div>
                              <div class="cit-extra"><a href="http://www.jimmunol.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=66/6/3602" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                           </div>
                           
                        </li>
                     </ol>
                  </div>
                  
                  
                  
                  
                  
                  
                  
                  
                  
                  
                  
                  
                  
                  
                  
               </div><span class="highwire-journal-article-marker-end"></span></div><span id="related-urls"></span><div xmlns="http://www.w3.org/1999/xhtml" id="cited-by"><h2>Articles citing this article</h2><ul class="cited-by-list"><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">The T-Cell Response to HIV </span> <cite><abbr title="Cold Spring Harbor Perspectives in Medicine" class="site-title">Cold Spring Harb Perspect Med</abbr> <span class="cit-print-date">2012 </span><span class="cit-vol">2<span class="cit-sep cit-sep-after-article-vol">:</span></span><span class="cit-pages"><span class="cit-first-page">a007054</span></span></cite>  </div><div class="cit-extra"><ul class="cit-views"><li class="first-item"><a href="http://perspectivesinmedicine.cshlp.org/cgi/content/abstract/2/11/a007054" rel="abstract">Abstract</a></li><li><a href="http://perspectivesinmedicine.cshlp.org/cgi/content/full/2/11/a007054" rel="full-text">Full Text</a></li><li class="last-item"><a href="http://perspectivesinmedicine.cshlp.org/cgi/reprint/2/11/a007054" rel="full-text.pdf">Full Text (PDF)</a></li></ul>  </div> </li><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">Potent Autologous and Heterologous Neutralizing Antibody Responses Occur in HIV-2 Infection across a Broad Range of Infection Outcomes </span> <cite><abbr title="Journal of Virology" class="site-title">J. Virol.</abbr> <span class="cit-print-date">2012 </span><span class="cit-vol">86<span class="cit-sep cit-sep-after-article-vol">:</span></span><span class="cit-pages"><span class="cit-first-page">930</span><span class="cit-sep">-</span><span class="cit-last-page">946</span></span></cite>  </div><div class="cit-extra"><ul class="cit-views"><li class="first-item"><a href="http://jvi.asm.org/cgi/content/abstract/86/2/930" rel="abstract">Abstract</a></li><li><a href="http://jvi.asm.org/cgi/content/full/86/2/930" rel="full-text">Full Text</a></li><li class="last-item"><a href="http://jvi.asm.org/cgi/reprint/86/2/930" rel="full-text.pdf">Full Text (PDF)</a></li></ul>  </div> </li><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">HIV Type 2 in New York City, 2000-2008 </span> <cite><abbr title="Clinical Infectious Diseases" class="site-title">Clinical Infectious Diseases</abbr> <span class="cit-print-date">2010 </span><span class="cit-vol">51<span class="cit-sep cit-sep-after-article-vol">:</span></span><span class="cit-pages"><span class="cit-first-page">1334</span><span class="cit-sep">-</span><span class="cit-last-page">1342</span></span></cite>  </div><div class="cit-extra"><ul class="cit-views"><li class="first-item"><a href="http://cid.oxfordjournals.org/cgi/content/abstract/51/11/1334" rel="abstract">Abstract</a></li><li><a href="http://cid.oxfordjournals.org/cgi/content/full/51/11/1334" rel="full-text">Full Text</a></li><li class="last-item"><a href="http://cid.oxfordjournals.org/cgi/reprint/51/11/1334" rel="full-text.pdf">Full Text (PDF)</a></li></ul>  </div> </li><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">T Cell Immunity in Acute HIV-1 Infection </span> <cite><abbr title="Journal of Infectious Diseases" class="site-title">The Journal of Infectious Disease</abbr> <span class="cit-print-date">2010 </span><span class="cit-vol">202<span class="cit-sep cit-sep-after-article-vol">:</span></span><span class="cit-pages"><span class="cit-first-page">S302</span><span class="cit-sep">-</span><span class="cit-last-page">S308</span></span></cite>  </div><div class="cit-extra"><ul class="cit-views"><li class="first-item"><a href="http://jid.oxfordjournals.org/cgi/content/abstract/202/Supplement_2/S302" rel="abstract">Abstract</a></li><li><a href="http://jid.oxfordjournals.org/cgi/content/full/202/Supplement_2/S302" rel="full-text">Full Text</a></li><li class="last-item"><a href="http://jid.oxfordjournals.org/content/jinfdis/vol202/Supplement_2/pdf/S302.pdf" rel="full-text.pdf">Full Text (PDF)</a></li></ul>  </div> </li><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">Influence of HLA Class I and HLA-KIR Compound Genotypes on HIV-2 Infection and Markers of Disease Progression in a Manjako Community in West Africa </span> <cite><abbr title="Journal of Virology" class="site-title">J. Virol.</abbr> <span class="cit-print-date">2010 </span><span class="cit-vol">84<span class="cit-sep cit-sep-after-article-vol">:</span></span><span class="cit-pages"><span class="cit-first-page">8202</span><span class="cit-sep">-</span><span class="cit-last-page">8208</span></span></cite>  </div><div class="cit-extra"><ul class="cit-views"><li class="first-item"><a href="http://jvi.asm.org/cgi/content/abstract/84/16/8202" rel="abstract">Abstract</a></li><li><a href="http://jvi.asm.org/cgi/content/full/84/16/8202" rel="full-text">Full Text</a></li><li class="last-item"><a href="http://jvi.asm.org/cgi/reprint/84/16/8202" rel="full-text.pdf">Full Text (PDF)</a></li></ul>  </div> </li><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">HIV-2 Genetic Evolution in Patients with Advanced Disease Is Faster than That in Matched HIV-1 Patients </span> <cite><abbr title="Journal of Virology" class="site-title">J. Virol.</abbr> <span class="cit-print-date">2010 </span><span class="cit-vol">84<span class="cit-sep cit-sep-after-article-vol">:</span></span><span class="cit-pages"><span class="cit-first-page">7412</span><span class="cit-sep">-</span><span class="cit-last-page">7415</span></span></cite>  </div><div class="cit-extra"><ul class="cit-views"><li class="first-item"><a href="http://jvi.asm.org/cgi/content/abstract/84/14/7412" rel="abstract">Abstract</a></li><li><a href="http://jvi.asm.org/cgi/content/full/84/14/7412" rel="full-text">Full Text</a></li><li class="last-item"><a href="http://jvi.asm.org/cgi/reprint/84/14/7412" rel="full-text.pdf">Full Text (PDF)</a></li></ul>  </div> </li><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">Gag-Specific CD4+ T-Cell Frequency Is Inversely Correlated with Proviral Load and Directly Correlated with Immune Activation in Infection with Human Immunodeficiency Virus Type 2 (HIV-2) but Not HIV-1 </span> <cite><abbr title="Journal of Virology" class="site-title">J. Virol.</abbr> <span class="cit-print-date">2008 </span><span class="cit-vol">82<span class="cit-sep cit-sep-after-article-vol">:</span></span><span class="cit-pages"><span class="cit-first-page">9795</span><span class="cit-sep">-</span><span class="cit-last-page">9799</span></span></cite>  </div><div class="cit-extra"><ul class="cit-views"><li class="first-item"><a href="http://jvi.asm.org/cgi/content/abstract/82/19/9795" rel="abstract">Abstract</a></li><li><a href="http://jvi.asm.org/cgi/content/full/82/19/9795" rel="full-text">Full Text</a></li><li class="last-item"><a href="http://jvi.asm.org/cgi/reprint/82/19/9795" rel="full-text.pdf">Full Text (PDF)</a></li></ul>  </div> </li><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">Higher Homologous and Lower Cross-Reactive Gag-Specific T-Cell Responses in Human Immunodeficiency Virus Type 2 (HIV-2) Than in HIV-1 Infection </span> <cite><abbr title="Journal of Virology" class="site-title">J. Virol.</abbr> <span class="cit-print-date">2008 </span><span class="cit-vol">82<span class="cit-sep cit-sep-after-article-vol">:</span></span><span class="cit-pages"><span class="cit-first-page">8619</span><span class="cit-sep">-</span><span class="cit-last-page">8628</span></span></cite>  </div><div class="cit-extra"><ul class="cit-views"><li class="first-item"><a href="http://jvi.asm.org/cgi/content/abstract/82/17/8619" rel="abstract">Abstract</a></li><li><a href="http://jvi.asm.org/cgi/content/full/82/17/8619" rel="full-text">Full Text</a></li><li class="last-item"><a href="http://jvi.asm.org/cgi/reprint/82/17/8619" rel="full-text.pdf">Full Text (PDF)</a></li></ul>  </div> </li><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">T Cells and Tuberculosis: Beyond Interferon-{gamma} </span> <cite><abbr title="Journal of Infectious Diseases" class="site-title">The Journal of Infectious Disease</abbr> <span class="cit-print-date">2008 </span><span class="cit-vol">197<span class="cit-sep cit-sep-after-article-vol">:</span></span><span class="cit-pages"><span class="cit-first-page">941</span><span class="cit-sep">-</span><span class="cit-last-page">943</span></span></cite>  </div><div class="cit-extra"><ul class="cit-views"><li class="first-item"><a href="http://jid.oxfordjournals.org/cgi/content/full/197/7/941" rel="full-text">Full Text</a></li><li class="last-item"><a href="http://jid.oxfordjournals.org/cgi/reprint/197/7/941" rel="full-text.pdf">Full Text (PDF)</a></li></ul>  </div> </li><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">Dendritic Cells Are Less Susceptible to Human Immunodeficiency Virus Type 2 (HIV-2) Infection than to HIV-1 Infection </span> <cite><abbr title="Journal of Virology" class="site-title">J. Virol.</abbr> <span class="cit-print-date">2007 </span><span class="cit-vol">81<span class="cit-sep cit-sep-after-article-vol">:</span></span><span class="cit-pages"><span class="cit-first-page">13486</span><span class="cit-sep">-</span><span class="cit-last-page">13498</span></span></cite>  </div><div class="cit-extra"><ul class="cit-views"><li class="first-item"><a href="http://jvi.asm.org/cgi/content/abstract/81/24/13486" rel="abstract">Abstract</a></li><li><a href="http://jvi.asm.org/cgi/content/full/81/24/13486" rel="full-text">Full Text</a></li><li class="last-item"><a href="http://jvi.asm.org/cgi/reprint/81/24/13486" rel="full-text.pdf">Full Text (PDF)</a></li></ul>  </div> </li><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">Role of Human Immunodeficiency Virus (HIV)-Specific T-Cell Immunity in Control of Dual HIV-1 and HIV-2 Infection </span> <cite><abbr title="Journal of Virology" class="site-title">J. Virol.</abbr> <span class="cit-print-date">2007 </span><span class="cit-vol">81<span class="cit-sep cit-sep-after-article-vol">:</span></span><span class="cit-pages"><span class="cit-first-page">9061</span><span class="cit-sep">-</span><span class="cit-last-page">9071</span></span></cite>  </div><div class="cit-extra"><ul class="cit-views"><li class="first-item"><a href="http://jvi.asm.org/cgi/content/abstract/81/17/9061" rel="abstract">Abstract</a></li><li><a href="http://jvi.asm.org/cgi/content/full/81/17/9061" rel="full-text">Full Text</a></li><li class="last-item"><a href="http://jvi.asm.org/cgi/reprint/81/17/9061" rel="full-text.pdf">Full Text (PDF)</a></li></ul>  </div> </li><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">Multiple-Cytokine-Producing Antiviral CD4 T Cells Are Functionally Superior to Single-Cytokine-Producing Cells </span> <cite><abbr title="Journal of Virology" class="site-title">J. Virol.</abbr> <span class="cit-print-date">2007 </span><span class="cit-vol">81<span class="cit-sep cit-sep-after-article-vol">:</span></span><span class="cit-pages"><span class="cit-first-page">8468</span><span class="cit-sep">-</span><span class="cit-last-page">8476</span></span></cite>  </div><div class="cit-extra"><ul class="cit-views"><li class="first-item"><a href="http://jvi.asm.org/cgi/content/abstract/81/16/8468" rel="abstract">Abstract</a></li><li><a href="http://jvi.asm.org/cgi/content/full/81/16/8468" rel="full-text">Full Text</a></li><li class="last-item"><a href="http://jvi.asm.org/cgi/reprint/81/16/8468" rel="full-text.pdf">Full Text (PDF)</a></li></ul>  </div> </li><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">Memory CD4+ T-Lymphocyte Loss and Dysfunction during Primary Simian Immunodeficiency Virus Infection </span> <cite><abbr title="Journal of Virology" class="site-title">J. Virol.</abbr> <span class="cit-print-date">2007 </span><span class="cit-vol">81<span class="cit-sep cit-sep-after-article-vol">:</span></span><span class="cit-pages"><span class="cit-first-page">8009</span><span class="cit-sep">-</span><span class="cit-last-page">8015</span></span></cite>  </div><div class="cit-extra"><ul class="cit-views"><li class="first-item"><a href="http://jvi.asm.org/cgi/content/abstract/81/15/8009" rel="abstract">Abstract</a></li><li><a href="http://jvi.asm.org/cgi/content/full/81/15/8009" rel="full-text">Full Text</a></li><li class="last-item"><a href="http://jvi.asm.org/cgi/reprint/81/15/8009" rel="full-text.pdf">Full Text (PDF)</a></li></ul>  </div> </li><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">Dynamic Relationship between IFN-{gamma} and IL-2 Profile of Mycobacterium tuberculosis-Specific T Cells and Antigen Load </span> <cite><abbr title="The Journal of Immunology" class="site-title">J. Immunol.</abbr> <span class="cit-print-date">2007 </span><span class="cit-vol">178<span class="cit-sep cit-sep-after-article-vol">:</span></span><span class="cit-pages"><span class="cit-first-page">5217</span><span class="cit-sep">-</span><span class="cit-last-page">5226</span></span></cite>  </div><div class="cit-extra"><ul class="cit-views"><li class="first-item"><a href="http://www.jimmunol.org/cgi/content/abstract/178/8/5217" rel="abstract">Abstract</a></li><li><a href="http://www.jimmunol.org/cgi/content/full/178/8/5217" rel="full-text">Full Text</a></li><li class="last-item"><a href="http://www.jimmunol.org/cgi/reprint/178/8/5217" rel="full-text.pdf">Full Text (PDF)</a></li></ul>  </div> </li></ul></div></div>
         <div style="height: 19302px;" id="col-2">
            
            <div class="article-nav sidebar-nav">
               <a href="http://www.jimmunol.org/content/176/11/6962.short" title="Previous article" class="previous">« Previous</a><span class="article-nav-sep"> | </span><a href="http://www.jimmunol.org/content/176/11/6982.short" title="Next article" class="next">Next Article »</a>
               
               <span class="toc-link">
                  				<a href="http://www.jimmunol.org/content/176/11.toc" title="Table of Contents">Table of Contents</a>
                  			</span>
               
               
            </div>
            <div class="content-box" id="article-cb-main">
               <div class="cb-contents">
                  <h3 class="cb-contents-header"><span>This Article</span></h3>
                  <div class="cb-section cb-slug">
                     <ol>
                        <li>
                           <div id="slugline">
                              
                              
                              	    
                              
                              <cite>
                                 	    <abbr title="The Journal of Immunology" class="slug-jnl-abbrev">

                                    The Journal of Immunology</abbr><span class="slug-pub-date" itemprop="datePublished">

                                    	    June 1, 2006 
                                    </span>
                                 	    <span class="slug-vol">

                                    vol. 176 
                                    </span><span class="slug-issue">

                                    no. 11 
                                    </span><span class="slug-pages">

                                    6973-6981
                                    </span>
                                 </cite>
                              
                              
                              
                           </div>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section cb-views">
                     <ol>
                        <li class="abstract-view-link primary"><a href="http://www.jimmunol.org/content/176/11/6973.abstract" rel="view-abstract">Abstract</a><span class="oa-view-right">&nbsp;Free</span><span class="viewspecificaccesscheck jimmunol;176/11/6973 abstract"></span></li>
                        <li class="notice full-text-view-link primary"><span class="variant-indicator">» <span>Full Text</span></span><span class="viewspecificaccesscheck jimmunol;176/11/6973 full"></span></li>
                        <li class="notice full-text-pdf-view-link primary"><a href="http://www.jimmunol.org/content/176/11/6973.full.pdf+html" rel="view-full-text.pdf">Full Text (PDF)</a><span class="viewspecificaccesscheck jimmunol;176/11/6973 reprint"></span></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-cat">
                     <h4 class="cb-section-header"><a href="#" class="collapse-toggle"><span class="view-more">-</span> <span>Classifications</span></a></h4>
                     <ol>
                        <li>
                           <ul class="subject-headings last-child">
                              <li><a class="tocsection-search" href="http://www.jimmunol.org/search?tocsectionid=HOST+DEFENSE&amp;sortspec=date&amp;submit=Submit">HOST DEFENSE</a></li>
                           </ul>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-stats">
                     <h4 class="cb-section-header"><a href="#" class="collapse-toggle"><span class="view-more">-</span> <span>Article Usage Stats</span></a></h4>
                     <ol>
                        <li class="usage-stats-link icon-link"><a href="http://www.jimmunol.org/articleusage?rid=176/11/6973" rel="nofollow">Article Usage Statistics</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-svcs">
                     <h4 class="cb-section-header"><a href="#" class="collapse-toggle"><span class="view-more">-</span> <span>Services</span></a></h4>
                     <ol>
                        <li class="alert-link icon-link"><a href="http://www.jimmunol.org/cgi/alerts/ctalert?alertType=citedby&amp;addAlert=cited_by&amp;cited_by_criteria_resid=jimmunol;176/11/6973&amp;saveAlert=no&amp;return-type=article&amp;return_url=http://www.jimmunol.org/content/176/11/6973.full">Alert me when this article is cited</a></li>
                        <li class="alert-link icon-link"><a href="http://www.jimmunol.org/cgi/alerts/ctalert?alertType=correction&amp;addAlert=correction&amp;correction_criteria_value=176/11/6973&amp;saveAlert=no&amp;return-type=article&amp;return_url=http://www.jimmunol.org/content/176/11/6973.full">Alert me if a correction is posted</a></li>
                        <li class="similar-link"><a href="http://www.jimmunol.org/search?qbe=jimmunol;176/11/6973&amp;citation=Duvall%20et%20al.%20176%20%2811%29:%206973&amp;submit=yes">Similar articles in this journal</a></li>
                        <li class="similar-link nodata"><div id="cb-loaded-isi-related-none">No Web of Science related articles</div></li>
                        <li class="similar-link"><a href="http://www.jimmunol.org/external-ref?access_num=16709858&amp;link_type=MED_NBRS" class="similar-link">Similar articles in PubMed</a></li>
                        <li class="cit-man-link icon-link cite-link"><a href="http://www.jimmunol.org/citmgr?gca=jimmunol;176/11/6973">Download to citation manager</a></li>
                        <li class="copyright-link icon-link"><a href="http://www.aai.org/ji/copyright.html"><img src="permissions.gif"></a></li>
                     </ol>
                  </div>
                  <div class="cb-section default-closed collapsed" id="cb-art-cit">
                     <h4 class="cb-section-header"><a href="#" class="collapse-toggle"><span class="view-more">+</span> <span>Citing Articles</span></a></h4>
                     <ol style="display: none;">
                        <li class="hw-citing-link"><a href="#cited-by">View citing article information</a></li>
                        <li><a xmlns="http://www.w3.org/1999/xhtml" href="http://www.jimmunol.org/external-ref?access_num=jimmunol;176/11/6973&amp;link_type=ISI_CITING&amp;external_url=http%3A%2F%2Fgateway.webofknowledge.com%2Fgateway%2FGateway.cgi%3FGWVersion%3D2%26SrcApp%3DPARTNER_APP%26SrcAuth%3Dstanwire%26KeyUT%3D000237754200065%26DestLinkType%3DCitingArticles%26DestApp%3DWOS_CPL%26UsrCustomerID%3D269fc60adb004b0b719031a97aedf5e9">Citing articles via Web of Science (48)</a></li>
                        <li><a href="http://www.jimmunol.org/external-ref?access_num=http://www.jimmunol.org/content/176/11/6973.abstract&amp;link_type=GOOGLESCHOLAR">Citing articles via Google Scholar</a></li>
                     </ol>
                  </div>
                  <div class="cb-section default-closed collapsed" id="cb-art-gs">
                     <h4 class="cb-section-header"><a href="#" class="collapse-toggle"><span class="view-more">+</span> <span>Google Scholar</span></a></h4>
                     <ol style="display: none;">
                        <li class="cb-art-gs-auth author-link"><a href="http://scholar.google.com/scholar?q=%22author%3ADuvall%20author%3AM.G.%22" class="cb-art-gs-auth author-link">Articles by  Duvall, M. G.</a></li>
                        <li class="cb-art-gs-auth author-link"><a href="http://scholar.google.com/scholar?q=%22author%3ARowland-Jones%20author%3AS.L.%22" class="cb-art-gs-auth author-link">Articles by  Rowland-Jones, S. L.</a></li>
                        <li class="cb-art-gs-rel similar-link"><a href="http://www.jimmunol.org/external-ref?access_num=http://www.jimmunol.org/content/176/11/6973.abstract&amp;link_type=GOOGLESCHOLARRELATED">Search for related content</a></li>
                     </ol>
                  </div>
                  <div class="cb-section default-closed collapsed" id="cb-art-pm">
                     <h4 class="cb-section-header"><a href="#" class="collapse-toggle"><span class="view-more">+</span> <span>PubMed</span></a></h4>
                     <ol style="display: none;">
                        <li class="cb-art-pm-cite cite-link icon-link"><a href="http://www.jimmunol.org/external-ref?access_num=16709858&amp;link_type=PUBMED" class="cb-art-pm-cite cite-link icon-link">PubMed citation</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="http://www.jimmunol.org/external-ref?access_num=Duvall%20MG&amp;link_type=AUTHORSEARCH" class="cb-art-pm-auth author-link">Articles by  Duvall, M. G.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="http://www.jimmunol.org/external-ref?access_num=Rowland-Jones%20SL&amp;link_type=AUTHORSEARCH" class="cb-art-pm-auth author-link">Articles by  Rowland-Jones, S. L.</a></li>
                        <li>
                           <ul xmlns="http://www.w3.org/1999/xhtml">
   <li>Pubmed/NCBI databases
      <ul>
         <li><a href="http://www.jimmunol.org/cgi/external_ref?id=pubmed_pcsubstance_mesh&amp;type=acheck&amp;target=pcsubstance&amp;pmid=16709858&amp;link_type=ENTREZLINKS">Substance via MeSH</a></li>
      </ul>
   </li>
   <li>Medline Plus Health Information
      <ul>
         <li><a href="http://www.jimmunol.org/cgi/external_ref?id=MEDPLUS&amp;type=llinks&amp;target=http%3A%2F%2Fwww.nlm.nih.gov%2Fmedlineplus%2Fblood.html&amp;pmid=16709858&amp;link_type=ENTREZLINKS">Blood</a></li>
         <li><a href="http://www.jimmunol.org/cgi/external_ref?id=MEDPLUS&amp;type=llinks&amp;target=http%3A%2F%2Fwww.nlm.nih.gov%2Fmedlineplus%2Fhivaids.html&amp;pmid=16709858&amp;link_type=ENTREZLINKS">HIV/AIDS</a></li>
      </ul>
   </li>
</ul>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section default-closed collapsed nodata" id="cb-art-rel">
                     <h4 class="cb-section-header"><a href="#" class="collapse-toggle"><span class="view-more">+</span> <span>Related Content</span></a></h4>
                     <ol style="display: none;">
                        <li class="nodata"><div id="cb-loaded-related-urls-none">No related web pages</div></li>
                     </ol>
                  </div>
               </div>
            </div>
            
            
            <div class="content-box" id="article-dyn-nav">
               <div class="cb-contents">
                  <h3 class="cb-contents-header"><span>Navigate This Article</span></h3>
                  <div class="cb-section" id="cb-art-nav">
                     <ol>
                        <li><a href="#content-block">Top</a></li>
                        <li><a href="#abstract-1">Abstract</a></li>
                        <li><a href="#sec-1">Materials and Methods</a></li>
                        <li><a href="#sec-8">Results</a></li>
                        <li><a href="#sec-16">Discussion</a></li>
                        <li><a href="#sec-17">Acknowledgments</a></li>
                        <li><a href="#sec-18">Disclosures</a></li>
                        <li><a href="#fn-group-1">Footnotes</a></li>
                        <li><a href="#ref-list-1">References</a></li>
                     </ol>
                  </div>
               </div>
            </div>
            
         </div>
         <div style="height: 19302px;" id="col-3">
            
            <div class="content-box" id="sidebar-current-issue">
               <div class="cb-contents">
                  <h3 class="cb-contents-header"><span>Current Issue</span></h3>
                  <div class="cb-section">
                     <ol>
                        <li><span><a href="http://www.jimmunol.org/content/current" rel="current-issue">May 15, 2013, 190 (10)</a></span></li>
                     </ol>
                  </div>
                  <div class="cb-section">
                     <ol>
                        <li>
                           <div class="current-issue"><a href="http://www.jimmunol.org/content/current" rel="current-issue"><img src="10.cover.gif" alt="Current Issue" height="89" width="67"></a></div>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section sidebar-etoc-link">
                     <ol>
                        <li><a href="http://www.jimmunol.org/cgi/alerts/etoc">Alert me to new issues of The Journal of Immunology
                              </a></li>
                     </ol>
                  </div>
               </div>
            </div>
            <div id="sidebar-global-nav">
               
               
               <ul class="button-list pub-links">
                  <li class="pub-link-old first"><a href="http://www.jimmunol.org/content/early/recent" title=""><span></span></a>
                     
                     <div class="new-link"><a href="http://www.jimmunol.org/content/early/recent">NEXT IN <em>THE JI</em></a></div>
                     
                  </li>
                  <li class="mfr-mfc">
                     <a href="http://www.jimmunol.org/reports/most-read">MOST READ</a> │ <a href="http://www.jimmunol.org/reports/most-cited">MOST CITED</a>
                     
                  </li>
                  <li><a href="http://www.jimmunol.org/site/misc/edboard.xhtml" title="EDITORS"><span>EDITORS</span></a></li>
                  <li><a href="http://www.jimmunol.org/site/subscriptions" title="SUBSCRIBE"><span>SUBSCRIBE</span></a></li>
                  <li><a href="http://www.jimmunol.org/site/misc/authorinstructions.xhtml" title="INFO FOR AUTHORS"><span>INFO FOR AUTHORS</span></a></li>
                  <li><a target="_top" href="http://ji.msubmit.net/" rel="external-nw" title="SUBMIT [opens in a new window]"><span>SUBMIT</span></a></li>
                  <li class="alerts-feeds last"> 
                     	<a href="http://www.jimmunol.org/site/subscriptions/etoc.xhtml">ALERTS</a> │ <a href="http://www.jimmunol.org/rss/">FEEDS</a>
                     
                  </li>
               </ul>
               	
               
            </div>
            <div class="col3-ads-one">
               
               
               <ul class="tower-ads">
                  <li class="position-ad">
                     <script type="text/javascript" src="oasis-side-1.js"></script>
                     </li>
                  <noscript>

                     <A HREF="http://ahs2.adhostingsolutions.com/oasisc.php?s=1892&amp;w=160&amp;h=160&amp;t=_blank"><img SRC="http://ahs2.adhostingsolutions.com/oasisi.php?s=1892&amp;w=160&amp;h=160&amp;u=ahs2.adhostingsolutions.com&amp;t=_blank"
                             width="160"
                             height="160"
                             border="0" /></A>
                  </noscript>
               </ul>
               
               
            </div>
            <div class="col3-ads-two">
               
               
               <ul class="tower-ads">
                  <li class="position-ad">
                     <script type="text/javascript" src="oasis-side-2.js"></script>
                     </li>
                  <noscript>

                     <A HREF="http://ahs2.adhostingsolutions.com/oasisc.php?s=1886&amp;w=160&amp;h=600&amp;t=_blank"><img SRC="http://ahs2.adhostingsolutions.com/oasisi.php?s=1886&amp;w=160&amp;h=600&amp;u=ahs2.adhostingsolutions.com&amp;t=_blank"
                             width="160"
                             height="600"
                             border="0" /></A>
                  </noscript>
               </ul>
               
               
            </div>
            <div class="sidebar-icon-group">
               
               <div class="pub-logo">
                  <a title="[opens in a new window]" target="_top" href="http://www.aai.org/" rel="external-nw"><img src="society_logo.gif" class="publisher-icon" alt="Society Logo"></a>
                  
               </div>
               
               <div class="hw-logo">
                  <a title="[opens in a new window]" target="_top" href="http://highwire.stanford.edu/" rel="external-nw"><img src="hplogo.gif" class="hw-icon" alt="HighWire Press Logo"></a>
                  
               </div>
               
            </div>
            
            
            
         </div>
         <div id="footer">
            
            <div class="bar">
               
               <div class="footer-group footer-col-left">
                  
                  <ul class="button-list footer-buttons">
                     <li class="first"><a href="http://www.jimmunol.org/" title="Home"><span>Home</span></a></li>
                     <li><a href="http://www.jimmunol.org/site/misc/infoforauthor.xhtml#aboutjournal" title="About"><span>About</span></a></li>
                     <li><a href="http://ji.msubmit.net/" title="Submit"><span>Submit</span></a></li>
                     <li><a href="http://www.jimmunol.org/site/misc/authorinstructions.xhtml" title="Author Info"><span>Author Info</span></a></li>
                     <li><a href="http://www.jimmunol.org/archive/" title="Archive"><span>Archive</span></a></li>
                     <li><a href="http://www.jimmunol.org/subscriptions/" title="Subscribe"><span>Subscribe</span></a></li>
                     <li><a href="http://www.aai.org/About/Publications/JI/copyright.html" title="Permissions"><span>Permissions</span></a></li>
                     <li><a href="http://www.jimmunol.org/site/misc/privacypolicy.xhtml" title="Privacy Policy"><span>Privacy Policy</span></a></li>
                     <li><a href="http://www.jimmunol.org/site/misc/addir.xhtml" title="Advertise"><span>Advertise</span></a></li>
                     <li><a href="http://www.jimmunol.org/cgi/feedback" title="Contact"><span>Contact</span></a></li>
                     <li class="last"><a href="http://www.jimmunol.org/help/" title="Help"><span>Help</span></a></li>
                  </ul>
                  
                  <p class="copyright">
                     <a href="http://www.aai.org/">Copyright ©2013 by The American Association of Immunologists, Inc. All rights reserved </a></p>
                  
               </div>
               	  
               <div class="footer-group footer-col-right">
                  
                  <ul class="issns">
                     <li>
                        <span>Print ISSN: </span>
                        <span class="issn">0022-1767</span>
                        
                     </li>
                     <li>
                        <span>Online ISSN: </span>
                        <span class="issn">1550-6606</span>
                        
                     </li>
                  </ul>
                  
               </div>
               
            </div>
            
         </div><script type="text/javascript">

        var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
        document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
        </script><script src="ga.js" type="text/javascript"></script><script type="text/javascript">

        try {
        var pageTracker = _gat._getTracker("UA-24168501-1");
        pageTracker._trackPageview();
        } catch(err) {}
        </script></div>
   
<div id="fancybox-tmp"></div><div id="fancybox-loading"><div></div></div><div id="fancybox-overlay"></div><div id="fancybox-wrap"><div id="fancybox-outer"><div class="fancybox-bg" id="fancybox-bg-n"></div><div class="fancybox-bg" id="fancybox-bg-ne"></div><div class="fancybox-bg" id="fancybox-bg-e"></div><div class="fancybox-bg" id="fancybox-bg-se"></div><div class="fancybox-bg" id="fancybox-bg-s"></div><div class="fancybox-bg" id="fancybox-bg-sw"></div><div class="fancybox-bg" id="fancybox-bg-w"></div><div class="fancybox-bg" id="fancybox-bg-nw"></div><div id="fancybox-content"></div><a id="fancybox-close"></a><div id="fancybox-title"></div><a href="javascript:;" id="fancybox-left"><span class="fancy-ico" id="fancybox-left-ico"></span></a><a href="javascript:;" id="fancybox-right"><span class="fancy-ico" id="fancybox-right-ico"></span></a></div></div></body>
</html>
